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INTRODUCTION
The structure and functions of the cornea
The human eye is a sensory organ, which detects light waves and gives us the
sense of sight, through which we can observe and learn the surrounding world. It is
estimated that about 80% of information we receive comes from the sight. The eye
works as a camera. The incoming light waves from an object enter the eye through the
cornea, which acts as a lens to refract the light. The light continues to pass through a
number of tissues, as it passes through the inner components of a camera. The light is
eventually detected by the retina, which is equivalent to the film of a camera, and
converted into electrical signals to transmit to the brain, where it is interpreted or “seen”
as a visual image.
The cornea is the clear, dome-shaped structure at the front of the eye. It is
named the “window” of the sight. It is covered by the tear film and physically protected
by the eyelids in the front. The cornea is structurally divided into five layers: the
epithelium, Bowman's layer in human and the basement membrane in rodents and
other animals, the stroma, Descemet's membrane, and the endothelium (Fig. 1). The
cornea is transparent and devoid of blood vessels, and is well known as an immuneprivileged site in the human body. Disruption of the structure, for example,
vascularization or scar formation, would cause the cornea to lose its transparency,
leading to visual impairment. The cornea is extremely abundant in free nerve endings
and exquisitely sensitive to foreign objects. Even the smallest piece of dust on the
cornea would cause significant discomfort and irritation.
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Figure 1 The structure of the cornea. The cornea can be divided into five
layers. From anterior to posterior: epithelial layer, Bowman’s layer, stromal
layer, Descemet’s layer, and endothelial layer. Open access image
provided by Discoveryeye. http://discoveryeye.org/corneal-transplantsurgery-terms-defined/
The corneal epithelium is the stratified epithelium consisting 5-7 layers of cells
covering the cornea and forms the first physical, chemical, and biological barrier of the
eye against external environment. The tear film on the epithelial surface contains
lysozyme, lactoferrin, IgA, etc., which have bacteriostatic or bactericidal activity (Ueta
and Kinoshita, 2010). The membrane-tethered mucins, including MUC1, MUC4, and
MUC16, form a dense glycocalyx to serve as a physical barrier to prevent bacterial
adherence on the surface of corneal epithelium (Govindarajan and Gipson, 2010). The
apical layer of the stratified corneal epithelium possesses tight junctions, the most
important biological barrier against microbial infection and chemical insults. However, if
this barrier function is compromised, the cornea is susceptible to various insults. In
response to microbial insults, corneal epithelial cells can produce antimicrobial peptides,
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including β-defensins, cathelicidin (LL37), and calprotectin (the heterodimer S100A8
and A9), etc. to restrict the availability of nutrition to microbes and/or to kill microbes
directly. Recently, a novel class of antimicrobial peptides has been identified that are
processed from cytokeratin-6A in corneal epithelial cells (Tam et al., 2012). These
keratin-derived antimicrobial peptides (KDAMPs) can bind to bacteria directly and
induce permeabilization. They have a broad spectrum of anti-microbial activity.
The Bowman’s membrane is a smooth, acellular collagen layer, which serves as
a barrier between the epithelium and the stroma to prevent direct traumatic insults in the
corneal stroma. The stroma takes up to 90% of the corneal thickness and consists of
parallel collagen fibers with sparsely embedded keratinocytes. Healthy corneal
epithelium and stroma contain resident immune cells, including heterogeneous
macrophages and dendritic cells (Brissette-Storkus et al., 2002; Chinnery et al., 2008;
Chinnery et al., 2007; Hamrah and Dana, 2007; Hamrah et al., 2003) (Fig. 2). These
cells initiate host response to pathogens and secrete cytokines and chemokines to
recruit immune cell infiltration to mediate pathogen killing as well as inflammatory
responses. The Descemet’s membrane is a thin acelluar layer that acts as the modified
basement membrane of the endothelium. The endothelium is a single cellular layer
responsible for the transportation of fluid and solutes between the aqueous and the
stroma, maintaining the hydration of the stroma.
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Figure 2 Resident immune cells in the cornea. (A) Corneal image from
CX3CR1GFP+ mouse showing normal cornea is populated with resident bone
marrow derived cells. (B) Schematic graph showing the distribution of
dendritic cells (DC) in both the epithelial and stromal layer, and
macrophages in the stromal layer. (C) Mouse corneal whole mount images
in panels 1-4 illustrating each cell population in Fig. 1B. Panel 1: Wild type
cornea incubated with MHC II antibody demonstrating the expression of
epithelial DCs. Panel 2: Cornea from CD11c eYFP mouse incubated with
MHC II antibody demonstrating the expression of stromal DC. Panel 3:
Cornea from CX3CR1GFP+ mouse incubated with CD11b antibody
demonstrating the expression of macrophages in the stroma. Panel 4: Wild
type cornea incubated with MHC II antibody demonstrating the presence of
membrane nanotube between MHC II+ cells. Images obtained from NIH
Public Access manuscript (Pearlman et al., 2013)
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Infectious keratitis
Infectious keratitis is caused by pathogens including bacteria, viruses, fungi, and
protozoa to invade the cornea and cause abrasion and loss of corneal epithelium, with
inflammation in the underlying stroma (Keay et al., 2006). Infectious keratitis is also
named as “ulcerative keratitis” because of its characteristic defects in the corneal
epithelium. Clinical signs and symptoms include inflammation, irritation, and discharge.
The infected cornea appears to be red and swollen. The inflammation causes the
cornea to lose its transparency, presenting as corneal opacity. Since the cornea is richly
innervated, the irritation of the cornea causes copious tear production, sensitivity to
light, and extremely pain and discomfort. The diseased pathogens, epithelial cells, and
infiltrating cells (mainly neutrophils) are presented as discharge. Frequently, certain
pathogens have their specific presentations other than the general signs and symptoms.
Infectious keratitis is a medical emergency that requires prompt diagnosis and
treatment. The induced inflammation would eventually cause neovascularization and
scaring in the cornea, leading to vision impairment or loss.
Predisposing factors of infectious keratitis
The incidence of infectious keratitis varies among different reports, from 6.3 to 11
per 100, 000 populations per year (Erie et al., 1993; Lam et al., 2002). The prevalence
and the spectrum of causative pathogens largely depend on climate and predisposing
factors. While Candida is the predominant fungal species in temperate climates
(Ritterband et al., 2006; Tanure et al., 2000; Tuft and Tullo, 2009), filamentous fungi
account for the majority of fungal keratitis in tropical or subtropical areas, with Fusarium
and Aspergillus as prevalent fungi, respectively (Chander and Sharma, 1994; Houang et
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al., 2001; Liesegang and Forster, 1980; Upadhyay et al., 2001; Wong et al., 1997).
Infectious keratitis caused by other etiological agents, however, does not correlate with
geographical location or environmental factors in such an obvious way. Intact cornea of
a healthy individual is extremely resistant to infection. Majority of patients (87%) have at
least one predisposing factor when the infection occurs (Pachigolla et al., 2007). Risk
factors include ocular trauma, extended contact lens wear, chronic ocular surface
disease, ocular surgery, or systemic immune compromised diseases, etc. (Bourcier et
al., 2003; Dart et al., 1991; Fong et al., 2004; Keay et al., 2006; Wong et al., 2003).
Ocular trauma and extended contact lens wear are the two most preventable risk
factors in young age population (Bourcier et al., 2003; Keay et al., 2006).
Contact lens as a major predisposing factor
As people are enjoying the convenience and cosmetic effects brought by contact
lens, infections keratitis accompanies the benefits, and continues to be problematic
despite decades of research. Contact lens wear is the predominant risk factor for
infectious keratitis in developed counties (Keay et al., 2006; Schein et al., 2005).
Multiple reports have proved that lens material is not an independent risk factor (Dart et
al., 2008; Stapleton et al., 2008). Poor hygiene and extended wear are the two major
risk factors (Dart et al., 1991; Keay et al., 2009; Schein et al., 1989). During contact lens
wear, a number of factors would increase the chance of microbial contamination on
ocular surface, including microbe entry through outside air environment, finger contact
with lens, contact lens, care solution, and storage case. Risks factors include infrequent
lens disinfection or case cleaning, hand contamination before handling lens, self-poor
general hygiene, and lower socioeconomic class (Dart et al., 2008; Dart et al., 1991;
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Keay et al., 2009; Radford et al., 1998; Stapleton et al., 2008). It is well known that
contamination does not always end up with infection. Contamination is necessary for
infection, but it is not sufficient. Infection further requires the adaptation of microbes and
the physiological changes of corneal response.
Extended contact lens wear fulfills these other two requirements, and hence
becomes the most significant risk factor. It is reported that infection occurs in one week
after P. aeruginosa-contaminated lens being placed on a rat cornea (Tam et al., 2010).
Further research demonstrates that extended wear facilitates microbe growth and
formation of biofilms on the posterior side of lens surface (Tam et al., 2010). The
biofilms foster microbial adaptation on corneal surface and render microbes more
resistant to disinfectant or antibiotics. More importantly, during the extended “incubation
time” with corneal epithelial cells, microbes are able to alter gene expression to
enhance virulent factors to invade corneal epithelial cells (Fleiszig and Evans, 2010).
Therefore, extended wear allows microbes to gain more time to prepare them to
penetrate host cells.
On the other hand, extended contact lens wear alters the defensive ability of
corneal epithelial cells against microbial invasion. It is reported that after extended
contact lens wear (3d), in vitro cultured corneal epithelial cells lost their ability to upregulate antimicrobial peptides, such as human β-defensin-2 (hBD2), when they were
challenged with bacterial components (Maltseva et al., 2007; Mun et al., 2009). The tear
film contributes to corneal defense against infection (Fleiszig et al., 2003; Kwong et al.,
2007; McNamara et al., 2005). Contact lens being placed on the cornea may disrupt
tear biochemistry on the ocular surface (Fleiszig and Evans, 2010). The tear film may
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be excluded out the corneal surface if contact lens is placed too close. The placement
of contact lens may disrupt or shut down tear exchange between anterior and posterior
lens compartments (Paugh et al., 2001). During extended wear, the lack of tear
exchange may hamper the clearance of microbes on the corneal surface, as
demonstrated by more infectious keratitis has been found in soft lens wearers than rigid
gas-permeable lens wearer since soft lens permits less tear exchange (McNamara et
al., 1999). In addition, long-term contact lens wear inhibits normal shedding of corneal
epithelial cells (Cavanagh et al., 2002), causes corneal epithelial thinning (Cavanagh et
al., 2002), and leads to the formation of membrane lipid rafts on corneal epithelial cells
(Robertson et al., 2007). Lipid rafts would enhance the internalization of bacteria in
corneal epithelial cells. Extended contact lens wear also induces a hypoxic environment
in corneal epithelial cells, thereby increasing bacterial invasion and inflammatory
cytokine activation (Zaidi et al., 2004). Therefore, contact lens wear becomes a
significant risk factor for corneal infection.
P. aeruginosa (PA)
There are 80-140 million contact lens wearers around the world, presenting a
significant risk for microbial keratitis (Stapleton et al., 2007). PA remains the
predominant isolated pathogen associated with contact lens related keratitis (Stapleton
and Carnt, 2012). The strong correlation between PA and contact lens-related keratitis
is intriguing. As a matter of fact, before the invention of contact lens, PA was a rare
isolate from microbial keratitis. A battle of research undergoes to explore the reasons
why PA can preferably exploit the niche created by contact lens.
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One of the most important factors is PA has a large genome size. The genome of
PA strain PAO1 has been completely sequenced and contains 6.3 million base pairs,
the largest bacterial genome sequenced so far (Stover et al., 2000) (Fig. 3). The
genome has 5, 570 predicted open reading frames (ORFs), denoting its genetic
complexity (Stover et al., 2000). PA has the largest proportion of genes devoted to the
regulatory system, for example, transcriptional regulators and environmental sensors,
permitting it to adapt to and thrive in diverse environments (Stover et al., 2000). In
addition, PA has the capacity to metabolize a wide variety of organic substrates,
contributing to its enzymatic modification and degradation of antibiotics (Stover et al.,
2000). Specially, PA has four multidrug efflux systems that are members of resistancenodulation-cell division (RND) family, which confer the intrinsic resistance of PA to
antibiotics and disinfectants (Nikaido, 1998; Westbrock-Wadman et al., 1999). The size
and complexity of PA genome reflex its evolutionary adaptation to diverse environment
and resistance to antimicrobial substances.

10

Figure 3 The genome of P. aeruginosa strain PAO1. Each tick in the
outermost circle represents 100kb. PAO1 contains a total of 6,264,403 bp
genes. The genes are color-coded according to their functional categories and
direction of transcription. The outer band is the plus strand; the inner band is
the minus strand. Detailed description can be found in the cited article. (Stover
et al., 2000)
Virulence factors play important roles in PA invasion and infection. A key
mechanism that PA uses to control the expression of virulence factors is through
quorum sensing (QS). Quorum sensing is a global gene regulatory system that
organisms use to respond to surrounding environment (Willcox et al., 2008). Organisms
secrete signaling molecules to surrounding environment. When a certain threshold
concentration is reached, the molecules can be detected by specific receptor proteins to
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initiate signal transduction and induce QS-controlled gene expression. It is reported that
as many as 10% of PA genome is controlled by QS (Schuster et al., 2003; Wagner et
al., 2003; Willcox et al., 2008). Many of these genes directly or indirectly mediate the
pathogenesis of PA and its persistence in host cells (Fig. 4). The acylated homoserine
lactone (AHL) QS system seems to be routinely used by a variety of pathogenic Gramnegative bacteria, including PA (Willcox et al., 2008). Two hierarchical QS circuits exist
in PA to respond to AHL signals: the primary Las system (Gambello and Iglewski, 1991)
and secondary Rhl system (Brint and Ohman, 1995; Pearson et al., 1997). Las system
encodes the proteins LasI and LasR (Gambello and Iglewski, 1991). LasI has catalytic
ability and LasR is a DNA-binding transcription regulator. LasI mediates the production
of the AHL molecule N-3-oxododecanoyl-L-homoserine lactone (3O- C12-HSL)
(Pearson et al., 1994), which, accompanied by LasR, binds to the promoters of QScontrol genes to regulate virulence factor expression, such as lasB (elastase), aprA
(alkaline protease), and eoxA (exotoxin A) (Chapon-Herve et al., 1997; Gambello and
Iglewski, 1991; Gambello et al., 1993; Passador et al., 1993; Pessi and Haas, 2000;
Seed et al., 1995; Storey et al., 1998; Toder et al., 1994; Toder et al., 1991). The
expression of QS-regulated genes can positively feedback to the Las circuit to induce
more AHL production, and in the meantime, induce a secondary QS circuit, the Rhl
system (Pearson et al., 1995; Seed et al., 1995). The Rhl system consists of RhlI and
the receptor, RhlR (Brint and Ohman, 1995; Ochsner et al., 1994; Pearson et al., 1995;
Pearson et al., 1997). RhlI synthesizes N- butyryl-L-homoserine lactone (C4-HSL),
which can bind to RhIR when the concentration reaches a certain threshold to induce
the expression of QS-control genes, including rhlAB (rhamnolipid synthesis genes),
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rpoS (the stationary-phase sigma factor), lecA (type-1 lectin), lecB (type-II lectin), and
genes involved in pyocyanin production, et al. (Brint and Ohman, 1995; Latifi et al.,
1995; Ochsner et al., 1994; Pearson et al., 1997; Pessi and Haas, 2000; Winzer et al.,
2000). In addition, there is a third PA QS signal, the Pseudomonas quinolone signal
(PQS), which senses the balanced production of 3O-C12-HSL and C4-HSL (Pesci et
al., 1999). The production and bioactivity of PQS intimately depend on both the Las and
Rhl QS systems (McGrath et al., 2004). The PQS can mediate the transcription of Rhldependent PA virulence genes, such as pyocyanin and rhamnolipid (Deziel et al.,
2004). Thus, QS controls an arsenal of virulence gene expression to facilitate PA
pathogenesis.
Virulence factors of PA
PA is ubiquitous in environment and may be present in ocular surface in healthy
individuals. The physio-chemical characteristics of bacterial surface often influence its
adhesive ability. Bacteria with hydrophobic surface tend to adhere better than
hydrophilic bacteria. It is reported that PA GSU#3 has a surface water contact angle of
132 degrees, which is much higher than that of S. aureus strains (around 20-36
degrees), demonstrating the hydrophobicity of PA (Bruinsma et al., 2001; Klotz et al.,
1989). This prominent phenomenon contributes to its adhesion and colonization to
contact lens and storage case.
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Figure 4 PA virulence factors regulated by quorum sensing (QS)
system. ROS: reactive oxygen species. PMN: polymorphonuclear leukocyte.
(Winstanley and Fothergill, 2009)

Type Three Secretion System (TTSS) is a protein appendage found in many
pathogenic Gram-negative bacteria, including PA. The structure of TTSS consists of two
parts: the base and the needle (Fig. 5). The base anchors in the membranes of Gramnegative bacteria; the needle starts at the cytoplasm of the bacteria, passes through the
inner and outer membranes and protrudes from the cells (Cornelis, 2006; Moraes et al.,
2008). The needle helps bacteria to detect the presence of eukaryotic cells. Once the
needle is inserted into eukaryotic membrane, the effector proteins from TTSS would
pass through the needle and be secreted directly into eukaryotic cells, where they exert
a number of effects. Four effector proteins have been identified so far: exoS, exoU,
exoY, and ExoT. Based on the presence of particular effector proteins of TTSS, PA
strains can be divided into two subgroups: invasive stains and cytotoxic strains,
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expressing exoenzymes S (exoS) and U (exoU), respectively (Stapleton and Carnt,
2012). PA with exoS invades epithelial cells, proliferates inside the cells, and induces
cell death through the disruption of host cell cytoskeleton (Barbieri and Sun, 2004). PA
expressing exoU proliferates extracellularly. ExoU is a potent cytotoxin that can directly
cause damage to epithelial cell membrane, and induce a cascade of inflammation (Sato
and Frank, 2004). Therefore, TTSS plays an important role in the pathogenesis of PA.

Figure 5 Structure of the Type Three Secretion System (TTSS) of PA.
TTSS consists of a base and a needle complex. When the needle complex
detects and anchors to host cells, effector toxins including ExoS, ExoT,
ExoY, and ExoU would be injected directly into the host cells through the
needle complex. (Pearlman et al., 2013)
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Flagellum is the major motility element of PA. Each PA cell has a single
flagellum, localizing at a cell pole. Flagellum provides bursts of straight line swimming
motions with occasional “tumbles” for bacterium to reorient itself. It also functions as an
adhesin and inflammation initiator related to the pathogenesis of PA (Miao et al., 2007).
Flagellum is mainly composed of flagellin, a globular protein that arranges itself helically
to form a hollow cylinder. The protein flagellin is encoded by the gene fliC. Based on its
reaction with specific polyclonal antibodies and molecular weight, flagellin can be
classified into two types: “a” type and “b” type. “A” type is a heterologous group of
proteins with molecular weight ranging from 45 to 52 kDa; “b” type is a homologous
protein with a molecular weight of 53 kDa (Brimer and Montie, 1998). Each stain of
bacteria only expresses one type of flagellin and does not undergo antigenic variation
(Winstanley et al., 1996). During infection, flagella can adhere to epithelial cells and the
component flagellin can be recognized by Toll like receptor 5 (TLR5) to elicit a strong
NF-κB-mediated inflammatory response (Miao et al., 2007). The presence of flagella in
bacteria has been linked to acute infection in disease models (Brimer and Montie, 1998;
Feldman et al., 1998), yet bacteria with down-regulation of flagella or aflagella are
frequently found in chronic infections (Wolfgang et al., 2004).
Bacteria organize themselves to form a structured community on a surface,
which is termed biofilm and intricately linked to QS (Bjarnsholt et al., 2009). Bacterial
communities are embedded in extracellular polymeric substance (EPS), the major
component of biofilm (50%-90% volume). EPS is comprised of polysaccharides, nucleic
acids, proteins, and lipids. It confers physical and chemical resistance to mechanical
forces and toxic chemical penetration, such as antibiotics and host defense molecules
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(Hall-Stoodley and Stoodley, 2009; Lieleg et al., 2011). The bacterial transcriptional
profile in a biofilm is tailored to limit the consumption of oxygen and nutrition to slow
growth rate. In the meantime, bacteria in a biofilm upregulate stress response genes,
leading to increased antibiotic resistance (Mah and O'Toole, 2001). The initiation of
biofilm is mediated by adhesions, such as type 4 pili, flagella, and fimbria (Mikkelsen et
al., 2011). This process partly depends on the Las and Rhl QS systems and partly on
environmental signals (Lopez et al., 2010). After the initiation, bacteria multiply as
microcolonies and secrete EPS to form a matrix. The mature biofilm forms a mushroomshaped structure. There are multiple channels in the structure to connect to outside
environment for exchanges of waste and nutrient (Kaplan, 2010). Subsequently, the
individual bacterium can shed off from the biofilm and be released to environment to
begin a new cycle of biofilm formation.
A number of other virulence factors also contribute to the pathogenesis of PA.
Lipopolysaccharide (LPS) localizes in the outer leaflet of PA membrane, consisting of
membrane-anchored lipid A, a polysaccharide core region, and highly variable Ospecific polysaccharide (O-antigen or O-polysaccharide) (King et al., 2009). LPS has
been subjected to intensive study due to its strong antigenicity and other important
characteristics. Proteases contribute to the pathogenesis by mediating the degradation
of immunoglobulin and disruption of epithelial tight junctions (Kipnis et al., 2006).
Alkaline protease is a zinc metalloprotease and able to degrade host complement
proteins and fibronectin (Laarman et al., 2012). It is reported that alkaline protease is
able to degrade free flagellin and hence prevents immune detection of flagellin by TLR5
(Bardoel et al., 2011). Elastase B (LasB) has been reported to degrade opsonizing lung
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surfactant proteins A and D (Mariencheck et al., 2003). The virulence of PA is
attenuated with ∆LasB mutant (Kuang et al., 2011). Protease IV is a serine protease
that can cause erosion of corneal epithelium through the degradation of complement
proteins, immunoglobulins, and fibrinogen (Engel et al., 1998). In sum, PA possesses
an arsenal of virulence factors involved in the pathogenesis of infection (Fig. 6).

Figure 6 Virulence factors produced by PA. Flagellin and type 4 pilli are
major adhesins to provide adhesion to epithelial cells. Flagellin and pilli,
along with LPS, are also major inducers of inflammation. TTSS, once
activated, is able to inject cytotoxins directly into host cells. Proteases can
degrade host immune components and disrupt tight junctions to facilitate
bacterial dissemination. Phospholipase can target host cell membranes.
Pyocyanin can disrupt the redox cycling system in host cells. Pyoverdine
captures Fe3+ to provide nutrition for bacteria. (Gellatly and Hancock, 2013)
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Animal models of PA keratitis
The devastating damage of infection is not only caused by virulence factors from
bacteria, but also caused by host inflammatory response.

The interplay between

pathogens and the host demands live animal models to study ocular infection, aiming at
new therapy development. The first animal model used in PA keratitis studies is New
Zealand White rabbit. Hessburg and coworkers developed a PA keratitis model by
passing a contaminated silk suture through rabbit corneal stroma (Penn et al., 1963).
This model was used in earlier studies to explore the mechanisms of PA proteases
(Wilson, 1970), and the effects of antibiotics on PA keratitis (Penn et al., 1963). Later,
Kessler et al. developed an intrastromal injection model: PA was directly injected into
the corneal stroma (Kessler et al., 1977). They used this model to study the proteolytic
activity induced by heat-killed PA in rabbit corneas. They found a massive infiltration of
polymorphonuclear leukocytes (PMNs) occurred during PA challenge; corneal damage
could be due to the proteolytic enzymes produced by the host. The method of
intrastromal inoculation has since been broadly used to study PA virulence factors and
to develop novel therapies in rabbits. Subsequently, investigators developed a topical
inoculation model. As has been mentioned previously, intact corneas are extremely
resistant to PA infection. Therefore, corneal scratch (Blaylock et al., 1990; Frucht-Pery
et al., 1995; Mannis, 2002), corneal abrasion (Michalova et al., 1996), or removal of
corneal epithelia (Michalova et al., 1996) was used to break the barrier functions of the
corneal epithelium before topical inoculation to induce PA keratitis in rabbits.
The advantage of using rabbit as an animal keratitis model is the large size of the
cornea. Therefore, many parameters used in human keratitis can be used in rabbits
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(Johnson et al., 1990). For example, the presence of fibrin in anterior chamber in PA
keratitis can be easily visualized in rabbits, but not in mice. However, rabbits are
formidably expensive to use for research, and many reagents, such as anti-rabbit
antibodies, are not commercially available for rabbit research. Mice, on the other hand,
have a number of advantages. Mice are relatively inexpensive, and can be bred in large
quantities in a short time period. Statistically significant number of mice can be used in
each experiment. A multitude of reagents are commercially available for mouse studies.
In addition, numerous strains, inbred or outbred, with different genetic background are
available in use for different study purposes. Specifically, the availability of genetically
modified mice allows researchers to study specific gene functions directly by knocking
in or out certain genes. Therefore, mice are currently widely used in PA keratitis studies.
Gerke and Magliocco first reported to use mice as a PA keratitis model (Gerke
and Magliocco, 1971). They successfully induced keratitis by making a 2-mm scratch in
mouse cornea before topical inoculation of PA. They studied the corneal and ocular
pathology of mouse keratitis and found that mice shared common characteristics with
other animals as well as with humans. They also experimented different wounding
methods: a 2-mm scratch, three needle incisions, a needle puncture, and direct
intrastromal injection. All four methods of wounding followed by PA inoculation can
induce a typical course of pathology in mouse cornea. They concluded that corneal
wounding is necessary to induce infection, but the absolute extent and methods of
making the wound are not critical. Yet, they found the intrastromal injection produced
the most consistent pathology among individual mouse. Most importantly, they
demonstrated that the severity of pathology is not quantitatively related to the number of
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PA in the cornea; the pathology lingers beyond the clearance of pathogens, further
justifying the necessity of animal models to study host response to infection.
Both the corneal scratch and intrastromal injection models have proved of
significant value in studying the immune response to PA keratitis. Although the
intrastromal injection model provides more consistent pathology between mice, it
bypasses the corneal epithelial layer to directly induce pathology in the stroma. The
corneal scratch model is more clinically relevant, giving that PA keratitis usually occurs
after corneal epithelial abrasion in patients. The corneal scratch model allows us to
study innate immunity of corneal epithelial cells in response to infection. The variations
in this procedure can be controlled by experienced hands. Therefore, we use the
scratch model in this study to induce PA keratitis.
Innate immunity
Since we live in an environment full of various microorganisms, one of the
fascinating problems in immunology is how host cells detect the presence of foreign
intruders. In the early 1900’s, the discovery of phagocytes by Elie Metchnikoff
established the roots of innate immunity (Chang, 2009). Innate immunity, an immediate
defensive

system,

detects

constitutive

and

conserved

molecules

unique

to

microorganisms (Medzhitov, 2001). Some of the microbial gene products provide
housekeeping functions and are essential to microbial survival, such as LPS and
lipoteichoic acids (LTAs) on bacterial cell wall. Although different strains and species of
microorganisms may have their unique chemical structures of housekeeping gene
products, they are always found to have common molecular patterns highly conserved
and invariant in a given class of microbes. For example, Gram-negative bacteria

21
constitutively express LPS. The O-antigen portion of LPS is variable in different species
of bacteria; however, the lipid-A portion remains invariant and is found in all Gramnegative bacteria. The conserved molecular patterns in microorganisms are named
pathogen-associated molecular patterns (PAMPs). Accordingly, the receptors that
recognize PAMPs in innate immune system are called pattern-recognition receptors
(PRRs) (Janeway, 1989).
PRRs in vertebrate innate immune system include Toll-like receptors (TLRs), Ctype lectin receptors (CLRs), retinoic-acid-inducible gene I (RIG-I)-like receptors (RLRs),
Nod-like receptors (NLRs), and cytosolic DNA receptors including absence in
melanoma 2 (AIM2) (Takeuchi and Akira, 2010). These PRRs are populated either on
cellular membranes or in cytosolic compartments to detect danger signals. Furthermore,
different families of PRRs can recognize the same ligand in different cellular locations.
For example, flagellin can be recognized by membrane bound TLR5 and cytosolic
NLR4 (Broz and Monack, 2013) . Such a system allows host cells to detect danger
signals in multiple levels to ensure no danger signals escape surveillance.
Toll-like receptors
Although the innate immune system has been discovered for over a century, its
importance was overshadowed by the fascinating adaptive immunity for a long period of
time. The discovery and characterization of TLRs have incited keen interest in the field
of innate immunity. Toll gene was first identified in Drosophila as a maternal-effect gene
that functions in fruit fly embryo development (Hashimoto et al., 1988). Later, Toll
mutant was found to be defective against fungal infection, demonstrating its function in
the immunity of fruit flies (Lemaitre et al., 1996). Subsequently, mammalian homologues
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of Toll were identified (Anderson, 2000; Medzhitov et al., 1997), and the importance of
innate immunity has since been greatly appreciated.
TLRs belong to the type I transmembrane receptor family. They consist of three
components: an amino (N)-terminal extracellular leucine-rich repeat (LRR) domain, a
single transmembrane region, and a carboxyl (C)-terminal intracellular Toll/ IL-1
receptor (TIR) domain (Gay and Gangloff, 2007). Thus far, ten TLRs (TLR 1-10) have
been identified in human and thirteen TLRs (TLR1-13) in mice (De Nardo, 2015). TLRs
can either localize on host cell plasma membrane to recognize microbial surface
molecules (e.g. TLR5 and TLR2), or in endolysosomal compartment to recognize
microbial nucleic acids (e.g. TLR3). Table 1 summarizes the cellular localizations and
microbial ligands of TLRs. In most cases, ligand binding induces dimerization of TLRs
(Bell et al., 2005; Gay et al., 2006); however, the endosomal TLRs, including TLR7,
TLR8, and TLR9, are reported to preform dimers before ligand recognition (Latz et al.,
2007; Tanji et al., 2013). The dimerization broadens the array of ligands recognized by
TLRs. For examples, TLR2 can form dimers with either TLR1 or TLR6 to recognize
triacylated lipoproteins or diacylated lipoproteins, respectively (Takeuchi et al., 2001;
Takeuchi et al., 2002).
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Table 1 TLR expression, localization, and ligands. Slight modification.
(De Nardo, 2015)

TLR4 is the first discovered mammalian Toll. It recognizes LPS on Gramnegative bacteria (Hoshino et al., 1999; Medzhitov et al., 1997; Poltorak et al., 1998;
Qureshi et al., 1999). TLR4 is expressed on a variety of cells types, predominantly on
immune cells such as macrophages and neutrophils (Medzhitov et al., 1997). Massive
inflammation caused by TLR4 signaling transduction has been implicated in fatal sepsis
syndrome (Karima et al., 1999). TLR5 recognizes flagellin, the only protein PAMP
sensed by TLRs (Hayashi et al., 2001). Flagellin is the main structural protein of
flagellum, a component vital for bacterial mobility. TLR5 is only expressed in the
basolateral side of simple epithelium and the basal layer of stratified epithelia (Gewirtz
et al., 2001). It is believed that the polarized expression of TLR5 is essential for the host
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to distinguish pathogenic and commensal pathogens, since pathogenic organisms can
cross the epithelial barrier (Medzhitov, 2001).
Broadly speaking, TLR activation triggers two major signaling pathways: MyD88dependent and TRIF-dependent pathways (Fig. 7). Both MyD88 and TRIF contain TIR
domain that can bind to the TIR domain of TLRs to connect the receptors to
downstream signaling molecules (O'Neill and Bowie, 2007). All TLRs, except TLR3,
recruit MyD88 to initiate signaling transduction. Due to suboptimal electrostatic surface
charges, TLR2 and TLR4 require additional bridging/sorting adaptor, MAL (also known
as TIRAP), to couple to the TIR domain of MyD88 (Dunne et al., 2003; Fitzgerald et al.,
2001; Horng et al., 2002). After binding to TLRs, MyD88 recruits the IL-1 receptor
associated kinases (IRAKs) through homotypic protein-protein interaction on the shared
death domain (DD) (Wesche et al., 1997). Activation of IRAKs recruits the E3 ubiquitin
(Ub) ligase, TNFR-associated factor 6 (TRAF6), to the complex. Once activated, TRAF6
is released into the cytosol and forms a complex with TAK1, TAB1 and TAB2/3 (Qian et
al., 2001). The newly formed cytosol complex activates an IKK complex to mediate
phosphorylation and degradation of IκB. Without the inhibition of IκB, NF-κB is released
and translocated into the nucleus to initiate inflammatory cytokine gene transcription
(Napetschnig and Wu, 2013).
TLR3 recruits and can directly interact with TRIF to initiate TRIF-dependent
signaling pathway (Oshiumi et al., 2003; Yamamoto et al., 2003a; Yamamoto et al.,
2002). While activation of TLR4 in the plasma membrane triggers MyD88 signaling
pathway, once TLR4 is endocytosed into endosomal compartments, it can recruit TRIF
through the bridging adaptor TRAM to initiate TRIF-dependent signaling pathway
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(Kagan et al., 2008; Yamamoto et al., 2003b). Engagement of TRIF with TLR3 or TLR4
provides docking sites for both TRAF6 and TRAF3 via TRAF6 binding motifs. TRAF6
recruitment activates RIP1 kinase to mediate NF-κB signaling cascade. TRAF3 can
associate with TBK-1 to activate IRF3, and eventually induce the type I interferon
production (Gohda et al., 2004; Sato et al., 2003).

Figure 7 Toll-like receptor signaling pathways. TLR signaling is mainly
mediated by MyD88-dependent or TRIF-dependent pathway to induce the
expression of pro-inflammatory cytokines and type I interferons. (O'Neill et
al., 2013)
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Activation of TLRs initiates a cascade of signal transduction events to promote
the expression of pro-inflammatory cytokines and chemokines (Chen et al., 2005;
Kumar et al., 2006; Vora et al., 2004). TLR stimulation also mediates the expression of
antimicrobial peptides, such as defensins, to kill pathogens directly (Redfern et al.,
2011). Chemokines recruits inflammatory cells from limbal capillaries to the site of
infection. Neutrophils are the predominant cell type recruited and essential for bacterial
killing and wounding healing. The generation of reactive oxygen species (ROS) (Leal et
al., 2012) and the formation of neutrophil extracellular traps (Brinkmann et al., 2004) are
believed to play critical roles in neutrophil-mediated bacterial killing. Inflammatory
cytokines also play an important role in microbial keratitis. IL-1β is a major mediator of
inflammatory response. It is an early responsive cytokine upon microbial keratitis, and is
able to induce other mediator expression and neutrophil infiltration. Depletion or
deficiency of IL-1β renders mice unable to clear pathogens (Karmakar et al., 2012;
Rudner et al., 2000). A certain amount of inflammatory response is beneficial to
pathogen clearance; however, prolonged unrestrained inflammation is devastating and
contributes to corneal destruction. The production of matrix metalloproteinase (MMPs)
from neutrophils can degrade base membrane and disrupt normal collagen matrix in the
stroma, resulting in corneal damage or even perforation (Nathan, 2006). A reduction of
neutrophil recruitment is related to reduced corneal damage in PA keratitis (Hazlett et
al., 1992). Therefore, the TLR-mediated inflammatory response must be precisely
regulated.
Flagellin-mediated innate immune protection
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The concept of endotoxin tolerance was first described by Beeson in 1946
(Beeson, 1946). Endotoxin tolerance refers to: pre-exposure of innate immune cells (in
vitro), or hosts (in vivo), with a low dose of endotoxin (e.g. LPS), renders them
transiently unresponsive to a subsequent large dose of endotoxin. For a long period of
time, the mechanism of endotoxin tolerance remained elusive. Later, researchers found
that alterations of the LPS-TLR4 signaling pathway are responsible for the tolerance
(Fan and Cook, 2004; Medvedev et al., 2000; Nomura et al., 2000). Endotoxin tolerance
is not only due to suppressing inflammatory signaling mediators, but also increasing
anti-inflammatory signaling molecules (Biswas and Lopez-Collazo, 2009) (Fig. 8).
Subsequently, investigators found that other microbacterial products, such as LTAs,
CpG DNA, and flagellin, can also induce protective innate immunity (Lehner et al., 2001;
Mizel and Snipes, 2002; Yeo et al., 2003). Besides self-tolerance, most microbial
products can desensitize the host immune response to a different type of microbial
products, a phenomenon termed cross-tolerance. Lehner MD et al. reported that prestimulation of both immune cells and mice with highly purified LTA resulted in the
suppression of signal transduction and cytokine release on subsequent LPS challenge,
and vice versa (Lehner et al., 2001). The Yi AK group also demonstrated that prestimulation of RAW264.7 cells with CpG DNA induced self- and cross-tolerance to a
second challenge with CpG DNA and LPS, respectively (Yeo et al., 2003).
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Figure 8 Endotoxin tolerance. (A) When re-challenged with LPS, host cells
show down-regulation of inflammatory cytokines and compromised antigen
presentation ability, yet up-regulation of anti-inflammatory cytokines, negative
regulators, scavenging receptors, and enhanced phagocytosis. (B) Endotoxin
tolerance suppresses the key inflammatory regulatory factor NF-κB to turn host
response into a refractory state. (Biswas and Lopez-Collazo, 2009)
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Mizel and coworkers first reported that prior exposure of human monocytes with
a minute amount of flagellin resulted in a state of hypo-responsiveness to a second
large dose of flagellin (Mizel and Snipes, 2002). They demonstrated that flagellininduced innate protection was not due to any change in the expression levels of TLR5
or IRAK, but was associated with blocking the release of IRAK from TLR5, rendering
IRAK without kinase activity. Besides immune cells, Sun and colleagues proved that
flagellin-induced tolerance also occurred in polarized intestinal epithelial cells (Sun et
al., 2007). Our previous data show that flagellin can induce a tolerant response in
human corneal epithelial cells (HCECs) (Kumar et al., 2007). To date, flagellin has been
found to induce protection against infection caused by a variety of pathogens.
Flagellin-induced protection is mediated by the activation of innate immunity
through TLR5 or NLR4 signaling pathway, independent of adaptive immunity (Liu et al.,
2014; Zhang et al., 2014a).

Flagellin pretreatment protects mice from pneumonia

caused by PA or Streptococcus pneumoniae (Munoz et al., 2010; Tolle et al., 2015; Yu
et al., 2010). Flagellin is also able to protect mice from intestinal rotavirus infection
(Zhang et al., 2014a). Our lab demonstrates that Flagellin pretreatment protects mouse
cornea from bacterial keratitis (P. aeruginosa) (Kumar et al., 2010; Kumar et al., 2008;
Yoon et al., 2013) or fungal keratitis (Candida albicans) (Gao et al., 2011; Liu et al.,
2014). Flagellin pretreatment alleviates clinical symptoms, enhances bacterial
clearance, and decreases neutrophil infiltration and pro-inflammatory cytokine secretion
in infected corneas. At the same time, flagellin pretreatment increases the expression of
cathelicidin-related antimicrobial peptide (CRAMP), inducible nitric oxide synthase
(iNOS), and C-X-C motif chemokine 10 (CXCL10). Flagellin can directly induce the
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expression of antimicrobial peptides in epithelial cells, or indirectly through dendritic
cells, which induce protective gene expression to mediate the protective effect. These
data demonstrate that consistent with endotoxin tolerance, flagellin-induced protection
is not only associated with reduced expression of pro-inflammatory cytokines, but also
related to enhanced expression of anti-inflammatory cytokines and antimicrobial
molecules to counter the inflammatory response and simultaneously enhance the innate
defense against infection.
In order to get a global picture of the altered gene expression in flagellin-induced
protection, we pretreated mouse corneas with flagellin before the inoculation of PA stain
PAO1, and collected mouse corneal epithelial cells at 6 hpi to run a genome-wide cDNA
microarray (Gao et al., 2013). As shown in Fig. 9, comparing with naïve corneal
epithelial cells, PAO1 infection resulted in a total of 675 genes with altered expression,
with 497 up- and 178 down-regulated genes; flagellin pretreatment before PAO1
infection resulted in a total of 929 genes with altered expression, with 890 upregulated
genes. While comparing the gene expression profiles in PAO1 infected corneal
epithelial cells with flagellin pretreatment to without flagellin pretreatment, we found that
there were a total of 209 differentially expressed genes, with 157 up- and 52 downregulated genes. The differentially expressed genes provide insights into their functions
in flagellin-induced protection. For example, the suppressed genes after flagellin
pretreatment (e.g. IL-1β and MMP13) suggest that they may be related to inflammatory
response and hence may cause damage to the cornea if left uncontrolled. The
augmented genes (e.g. S100A8/A9), on the other hand, may possess counter
inflammatory function or antimicrobial activity. Based on the cDNA microarray data, we
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constructed an innate defense network in flagellin-induced tolerance against microbial
infection in corneal epithelial cells, as shown in Fig 10 (Gao et al., 2013).

Figure 9 Gene expression profiles of mouse corneal epithelial cells after
PA strain PAO1 infection with or without flagellin pretreatment. (A)
Experimental design. Mouse corneal epithelial cells were pretreated with
flagellin for 24h before PAO1 challenge. Samples were collected at 6 hpi for
cDNA microarray analysis with naïve corneal epithelial cells as control. (B)
PAO1 infection with and without flagellin pretreatment altered the expression of
929 and 675 genes, respectively; there are a total of 209 differentially expressed
genes in corneal epithelial cells when compare PAO1 infection with flagellin
pretreatment to PAO1 infection without flagellin pretreatment. (Gao et al., 2013)
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Figure 10 A network of flagellin-induced protection in corneal epithelial
cells. Flagellin pretreatment may further induce, have no effect, or suppress
gene expression after subsequent microbial challenge, forming a complex
orchestrated counter inflammatory network. The altered gene products may be
located in the cytoplasm, nucleus, membrane, or secreted in extracellular
space. (Gao et al., 2013)

Flagellin has been explored to use as a vaccine candidate or a vaccine adjuvant
to protect mouse from an array of microbial pathogen. Harjai et al. reported
immunization of mice with divalent flagellin, including type “a” and “b” provides
homologous and heterologous protection against experimental PA urinary tract infection
(Sabharwal et al., 2016). The adjuvant effect of flagellin has been reported in many
vaccines to induce a potent and broad-spectrum immune protective effect against
various types of infection, including Yersinia pestis (Honko et al., 2006), Mycobacterium
tuberculosis (Le Moigne et al., 2008), influenza viruses (Hong et al., 2012; Skountzou et
al., 2010), West Nile viruses (McDonald et al., 2007), and human immunodeficiency
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virus (Vassilieva et al., 2011). Flagellin was fused to a vaccine gene to generate a DNA
vaccine to induce protective immunity against lethal PA pneumonia (Saha et al., 2007).
The advantages of flagellin as an adjuvant are: (1) Flagellin can activate host immune
system through the interaction with plasma membrane surface receptor TLR5 and
cytosolic receptor NLR4; (2) Flagellin is a stable protein that can be fused to other
vaccine proteins to incorporate multiple antigens in one molecule (Cuadros et al., 2004);
(3) Less antigen and adjuvant might be needed due to the adjuvant effect of flagellin
(Cuadros et al., 2004; Huleatt et al., 2007).
The flagellin protective effect has been extensively investigated to other areas
beyond infection. A pharmacologically optimized flagellin derivative, CBLB502, was
developed to study its effects. It is reported that Flagellin is a potent radioprotectant to
protect tissues from radiation-induced injury, indicating flagellin can be used as a mean
of supportive care to radiotherapy (Burdelya et al., 2012; Burdelya et al., 2008).
Administration of flagellin before induction of ischemia or immediately after reperfusion
can protect mice from ischemic-reperfusion syndrome (Fukuzawa et al., 2011). In
addition, flagellin can inhibit the growth of TLR5-expressiving tumors, such as lung
adenocarcinoma A549 (Burdelya et al., 2013; Burdelya et al., 2012). Furthermore,
administration

of

CBLB502

targets

the

liver

to

induce

the

expression

of

immunomodulatory factors and to recruit immune cell infiltration, resulting in growth
inhibition of liver metastases from tumors of various origins, regardless of their TLR5
expression status (Burdelya et al., 2013). Therefore, the protective effects of flagellin
are broad.
The IL-10 family

34
As previous stated, both causative organisms and host immune system
contribute to tissue damage. Therefore, the inflammatory response has to be finely
tuned and controlled in a timely manner. Several mechanisms have evolved to balance
the inflammatory response. One of them is the expression of cytokines that possess
anti-inflammatory and immunomodulatory characteristics, such as IL-10. IL-10 was
originally reported as a cytokine to counter IFN-γ response by T lymphocytes (Liu et al.,
1994). Ten years after the discovery of IL-10, various genetic approaches have
identified several cytokines structurally and functionally related to IL-10, which are
collectively referred to as the IL-10 family. Based primarily on their biological function,
the IL-10 family can be further grouped into three subgroups. The first group includes
only IL-10 itself. The second group is also referred to as the IL-20 subfamily, including
IL-19, IL-20, IL-22, IL-24 and IL-26. The third group is the type III IFN group, containing
IL-28A, IL-28B, and IL-29 (Ouyang et al., 2011).
IL-24 was the first discovered homolog to IL-10. It was identified by subtraction
hybridization from a human melanoma cell line (Jiang et al., 1995). IL-24 was initially
named melanoma differentiation associated gene-7 (MDA-7). MDA-7 protein expression
is found in normal melanocytes, gradually decreases during the progression of
melanomas, and disappears in metastatic melanomas (Ekmekcioglu et al., 2001; Huang
et al., 2001). Its cytokine property was not originally reported due to the abnormal long
signaling peptide encoded by MDA-7 gene. The IL-19 and IL-20 genes were discovered
by sequence database search for IL-10 homologs (Blumberg et al., 2001; Gallagher et
al., 2000). IL-22 was identified by cDNA subtractive hybridization as a gene expressed
in a mouse T cell line stimulated with IL-9, and was originally named IL-10-related T
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cell-derived inducible factor (IL-TIF) (Dumoutier et al., 2000a). IL-26 was discovered as
a cytokine expressed in Herpesvirus saimiri (HVS)-transformed human T cells, and
originally designated as AK155 (Knappe et al., 2000). Thus far, IL-26 has been reported
in humans and other vertebrates, but is absent in mice. IL-28A, IL-28B, and IL29 were
also identified by sequence database search for novel genes similar to IFN and the IL10 family cytokines (Kotenko et al., 2003; Sheppard et al., 2003). They were later
grouped into type III IFNs due to their functional similarity to type I IFNs (Fox et al.,
2009).
The genes encoding the IL-10 family cytokines are mapped to two chromosomal
loci, chromosome 1q32+2 and chromosome 12q14+3 (Kotenko, 2002) (Figure 11). The
genes for IL-10, IL-19, IL-20, and IL-24 cluster at chromosome 1q32+2, with IL-19, IL20, and IL-24 genes positioned in a head to tail manner and IL-10 gene in the opposite
direction toward the telomere. The genes for IL-22 and IL-26 are localized in
chromosome 12q14+3 within 100kb of the IFNG gene, orienting toward the telomere.
The IL-10 family cytokines share similar gene structures (Fig. 12). There are 5 exons
(exons 1-5) in the coding region and conserved positions of the intron/exon junctions of
each of the genes (Dumoutier et al., 2000b; Kotenko, 2002). However, IL-19, IL-22, and
IL-24 genes have two additional axons (exons 1a and 1b) upstream of the first common
exon 1 (Dumoutier et al., 2000b; Gallagher et al., 2000; Huang et al., 2001). In addition,
IL-19 gene has at least two alternative exons 1a, exon1a1 and exon1a2 (Gallagher et
al., 2000). The exon 1a2 in IL-19 gene and exon 1a in the IL-24 gene encode long
abnormal signal peptides, the presence of which in IL-19 and IL-24 proteins limits their
secretory ability. Alternatively, when exon 1a1 is present instead of exon 1a2 in IL-19
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mRNA or exon 1a is spliced out in IL-24 mRNA, these mRNAs are translated into
proteins with canonical signal peptides. The IL-19 and IL-24 proteins with the shorter
canonical signal peptides can be secreted into extracellular space at higher level. While
the proteins of IL-10 and IL-26 are biologically active as intercalated dimers
(Fickenscher and Pirzer, 2004; Zdanov et al., 1995), IL-19, IL-20, IL-22, and IL-24 are
functionally active as monomers (Chang et al., 2003; Nagem et al., 2002; Pletnev et al.,
2003; Sauane et al., 2003).

Figure 11 Chromosomal localization of the genes encoding cytokines from
the IL-10 family and receptors for the IL-10 family. (Kotenko, 2002)
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Figure 12 Genomic structures of IL-10 family cytokines and their
receptors. Proteins are depicted as thick colored bars. Arrows indicate former
intron positions. Gene transcripts are shown as strings of lines (exons) with
dotted lines (introns). (A and B) There are five exons in the coding region of
the genes of IL-10 family cytokines. IL-19 and IL-22 transcripts have one
additional exon (ex1a), whereas IL-24 transcripts have two additional exons
(ex1a and ex1b). IL-19 has two alternative transcript variants of ex1a (ex1a1
and ex1a2). When ex1a2 is present in IL-19 and ex1a is present in IL-24, an
additional Met codon (Mup) precedes the Met codon (M) encoded by ex1.
When translation starts from Mup, IL-19 and IL-24 proteins have elongated
abnormal signal peptides. Otherwise, when translation starts from M, IL-19
and IL-24 proteins possess canonical signal peptides. (C) There are seven
exons in the receptor genes for the IL-10 family cytokines, except IL-22BP
gene, which has five exons. (D) Hydropathy plot of IL-19 protein. Arrows
indicate positions of Mup and M codons. SP: signal peptide; TM:
transmembrane domain. (Kotenko, 2002)
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Receptor complexes
Cytokines bind to cell surface receptors to trigger intracellular signal transduction
to regulate downstream gene expression. Based on the primary structure of their
extracellular domains, cytokine receptors can be classified into two groups: class I and
class II receptors (Bazan, 1990a; Bazan, 1990b). The receptors for IL-10-related
cytokines belong to the class II receptors (Ho et al., 1993). The extracellular domains of
Class II receptors are characterized by the presence of two highly conserved disulfide
bridges and two fibronectin type III sub-domains in tandem with specific pattern of
proline and cysteine residues (Haque and Sharma, 2006; Kotenko and Langer, 2004),
and the absence of intact “WSXWS” motif in the region close to cell membrane (Bazan,
1990b). The receptor binding of the IL-10 family cytokines follows the paradigm of the
class II cytokine receptors, which was established based on the receptor complexes for
IFN-γ and IL-10 (Bach et al., 1997; Kotenko et al., 1997; Kotenko and Pestka, 2000;
Pestka et al., 1997). All the members of the IL-10 family signal through receptor
complexes comprising of a long-chain type 1 receptor and a short-chain type 2 receptor
(Trivella et al., 2010) (Table 2). For example, IL-10 signals through IL-10R1 and IL10R2 receptor complexes. Moreover, sharing receptor components has been found to
be a common feature in the IL-10 family. IL-10, IL-22, and IL-26 share IL-10R2 as the
common receptor chain, while utilizing IL-10R1, IL-22R1, and IL-20R1 as a unique
ligand binding chain, respectively (Kotenko et al., 1997; Xie et al., 2000). IL-19, IL-20,
and IL-24 share the IL-20R1 and IL-20R2 heterodimer receptor complex. In addition, IL20 and IL-24 can signal through the IL-22R1 and IL-20R1 receptor complex (Dumoutier
et al., 2001). Specificity is attained by unique receptor-cytokine interaction so the

39
interface is affinity tuned to transmit distinct signaling through shared receptor complex
(Logsdon et al., 2012). The receptor sharing does not seem to have mutual competitive
inhibition in their biological functions (Wolk et al., 2005). Additionally, IL-22 can bind to
IL-22 binding protein (IL-22BP), a soluble type 1 receptor that can block IL-22 signaling.

Table 2 The IL-10 family cytokines and
their transmembrane receptors. (Trivella et
al., 2010)

The genes encoding the receptors for the IL-10 family cytokines are scattered in
different chromosomes: IL-10R1 on chromosome 11, IL-10R2 on chromosome 21, IL20R1 and IL-22 BP on chromosome 6, IL-22R1 on chromosome 1, and IL-20R2 on
chromosome 3 (Fig. 11) (Kotenko, 2002). These genes also share conserved structures.
The coding regions of each receptor gene contain 7 exons except the IL-22BP gene,
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which has 5 exons and encodes a soluble receptor (Fig. 12). Exon 1 encodes the 5’UTR and the signal peptide; exon 2 to 5 encode the extracellular domain; exon 6
encodes part of the extracellular domain, transmembrane domain, and part of the
intracellular domain; exon 7 encodes the rest of intracellular domain and the 3’-UTR
(Mah and O'Toole, 2001).
In most cases, the extracellular domain of R1 receptor exhibits high affinity to
ligands and is the ligand-binding chain in the receptor complex. However, it is reported
that IL-24 exhibits significant binding to the R2 receptor, IL-20R2. The presence of R1
receptor, IL-20R1 or IL-22R1, dramatically increases binding affinity (Wang et al., 2002).
Neither IL-20R1 nor IL-22R1 can bind IL-24 alone (Wang et al., 2002). The cytoplasmic
domain of the receptors usually forms short α-helices organized in boxes, which are
responsible for molecular interactions with Janus kinases (JAKs). R1 receptor has a
long intracellular domain and it can be phosphorylated by JAK on Tyr residues after
ligand-receptor engagement. R2 receptor has a short intracellular domain that is
associated with JAK or Tyk2 tyrosine kinase, bringing an additional tyrosine kinase to
the receptor complex (Bach et al., 1996; Kotenko et al., 1995; Kotenko et al., 1997).
Ligand binding triggers conformational change of the receptor complex, and crossactivation of JAKs (Kotenko et al., 1996). Subsequently, the long R1 intracellular
domain recruits signal transducer and activator of transcription (STAT), which contain
SH2 domains, to the receptor complex (Kotenko et al., 1999). STAT3 is the key
transcription factor utilized by IL-10 and IL-20 subfamily cytokines, although STAT1 and
STAT5 can also be activated by IL-10 and IL-22 (Kotenko et al., 2003). Eventually,
STATs are phosphorylated by JAKs and then translocated as homo- or heterodimers
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into the nucleus to regulate target gene expression (Langer et al., 2004; Pestka et al.,
2004) (Fig. 13).

Figure 13 The schematic signaling pathway of the IL-10 family cytokines,
based on the IL-22 set of receptors. (1) In static state, inactivated R1 and
R2 chains are bound to JAKs. Inactivated STAT dimers are localized in the
cytoplasm. (2) Ligand binding to the receptors induces phosphorylation of
JAKs and the receptors. IL-22BP is a soluble decoy receptor that can bind to
IL-22 to prevent signal transduction. (3) STATs are recruited to the receptor
complex and get phosphorylated. (4) Activated STATs form dimers and
translocate to the nucleus to regulated related gene expression. (Trivella et al.,
2010)

JAK/STAT signaling pathway
In mammals, the JAK family consists of four members, JAK1, JAK2, JAK3, and
TYK2 (Bromberg et al., 1999; Williams, 2000). The JAK proteins are large kinases and
have a molecular weight of 120-140 kDa. They have seven homologous domains,
named as Janus homology domain (JH) 1-7. JH1 is a functional catalytic kinase
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domain, phosphorylation of which would lead to JAK protein conformational changes to
facilitate the interaction with its substrates. JH2 is a pseudokinase domain, which lacks
enzymatic activity and may act as a regulatory site or a docking site for STATs. The JH3
and JH4 domains are homologous to SH2 domains. JH4-JH7 are localized in the amino
terminal end of JAKs and involved in interaction with cytokine receptors and/or other
kinases (Kisseleva et al., 2002). Phosphorylation of JAKs requires two JAKs from the
same or different class to be proximal to each other. Different cytokine receptors may
preferentially activate specific JAKs to transduce signals inside the cells.
Seven STATs have been identified in mammalian cells: STAT1-4, STAT5a,
STAT5b, and STAT6 (Leonard and O'Shea, 1998). Their molecular masses range from
75 to 95 kDa. The STAT proteins share conserved structures, a SH2 domain and a C
terminal tyrosine residue (Y705 in mice). The interaction of the SH2 domain with
phosphorylated cytokine receptors may contribute to specific cytokine responses
(Schindler, 1999). The tyrosine residue can be phosphorylated by JAKs, which would
lead to STAT dimerization and subsequently translocation into the nucleus. STATs form
homodimers

or

heterodimers

through

the

interactions

of

the

SH2

domain-

phosphotyrosine of two monomers to form a reciprocal conformation (Grandis et al.,
2000; Leung et al., 1995). The serine at position 727 (S727) in STAT3 can also be
phosphorylated to enhance transcriptional activity (Boulton et al., 1995; Shen et al.,
2004; Wen and Darnell, 1997; Wen et al., 1995). STATs bind to DNA through a central
DNA-binding region to regulate related gene expression. After modulating gene
expression, phosphorylated STATs can be dephosphorylated by tyrosine phosphatases
and ready to for subsequent stimulation (Chung et al., 1997).
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STAT3 was first identified as a downstream signaling mediator of IL-6 two
decades ago (Lutticken et al., 1994; Standke et al., 1994; Zhong et al., 1994). Besides
IL-6, many other cytokines and growth factors can also activate STAT3, including
cytokines using receptor chain gp130, IL-20R cytokines, granulocyte colony-stimulating
factor (G-CSF), and growth factors that signal through protein tyrosine kinase receptors,
etc. (Ruff-Jamison et al., 1994; Standke et al., 1994; Tian et al., 1994; Zhong et al.,
1994). Increasing evidences prove that STAT3 plays important roles in immunity. Hyper
immunoglobulin E syndrome (HIES) is a human immunodeficiency syndrome caused by
autosomal dominant STAT3 inactivating mutations. Characteristic features in these
patients include recurring bacterial or fungal infection, elevated pro-inflammatory
response, and increased immunoglobulin E (IgE) in circulation (Freeman et al., 2009;
Freeman and Holland, 2008; Minegishi, 2009; Minegishi and Karasuyama, 2009). On
the other hand, over activation of STAT3 (e.g. single nucleotide polymorphisms) has
been linked to human autoimmunity diseases, for example, psoriasis and multiple
sclerosis (Jakkula et al., 2010; Tsoi et al., 2012). It is reported that some individuals with
juvenile-onset autoimmunity and lymphoproliferation are due to de novo activating point
mutations in STAT3 (i.e., GOF). GOF mutations in STAT3 elevate basal and cytokineinduced STAT3 transcriptional activity (Flanagan et al., 2014; Haapaniemi et al., 2015;
Milner et al., 2015; Vogel et al., 2015). Evidences from biochemistry and molecular
modeling prove that GOF mutations enhance STAT3 DNA binding affinity, which
presumably increases the transcriptional activity of STAT3 (Flanagan et al., 2014).
Upon bacterial or fungal infection, STAT3 is a key innate immune regulator that
provides increased numbers of the circulating neutrophils to contain infection. During

44
pathogen challenge, endothelial cells secrete increased numbers of G-CSF, the major
neutrophil growth factor (Boettcher et al., 2014). Upon the engagement of G-CSF with
its receptor, STAT3 is activated in bone marrow granulocytic progenitor cells to
stimulate the expression of C/EBPβ and c-Myc. These regulators enhance G1/S phase
progression to drive emergency granulopoiesis (Hirai et al., 2006; Johansen et al.,
2001; Zhang et al., 2010). STAT3 can directly enhance the transcriptional activity of
C/EBPβ and c-myc (Zhang et al., 2010). Moreover, upregulation of C/EBPβ by STAT3
activation enhance the association of C/EBPβ at the c-myc promoter. The presence of
STAT3 and C/EBPβ at the c-myc promoter causes disassociation of the negative
regulator C/EBPα from the promoter, hence increasing c-myc transcription (Johansen et
al., 2001; Zhang et al., 2010). Mice with STAT3 deletion in hematopoietic cells (e.g.
Tek-cre STAT3f/f mice) show defective ability in clearance of Listeria monocytogenes.
STAT3-deficient neutrophils and macrophages also have impaired ability to mount a
bactericidal response, demonstrating the critical roles of STAT3 in pathogen clearance
(Matsukawa et al., 2003; Nguyen-Jackson et al., 2010).
STAT3 not only induces neutrophil production to combat pathogen invasion, but
also restrains its production and limits inflammation to prevent destructive events
(Fielding et al., 2008; Lee et al., 2002). One of the key regulatory mechanisms is
through direct induction of the negative regulator SOCS3 (Croker et al., 2004) (more
detail later). STAT3 plays an important role in suppressing TLR signal transduction in
mature phagocytic cells. It is reported that STAT3-deficient macrophages and
neutrophils show enhanced pro-inflammatory cytokine expression upon TLR4 activation
(Takeda et al., 1999). STAT3 can inhibit NF-κB function by inducing the expression of
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transcriptional repressors and co-repressors, suggesting an indirect mechanism of
STAT3 in restraining inflammation (El Kasmi et al., 2007). In addition, STAT3 was found
to directly repress Ube2n gene transcription, which encodes the protein Ubc13, a key
E2 ubiquitin-conjugating enzyme. Ubc13 is required for Receptor Activator of NF-κB
(RANK) and TLR4 signaling (Zhang et al., 2014b). Therefore, STAT3 exerts a broad
anti-inflammatory function either by direct induction of the negative regulator or
inhibition of NF-κB or MAPK signaling pathway.
Cellular sources and targets of the IL-10 family cytokines
The expression profiles of the IL-10 family cytokines and their receptors are
fundamental for our understanding the biological functions of these cytokines. To this
end, Malefyt and colleagues conducted a study to comprehensively analyze the cellular
sources and targets of the IL-10 family cytokines by using cDNA libraries obtained from
a panel of human hematopoietic cells as well as human tumor cell lines (Nagalakshmi et
al., 2004). The expression of the IL-10 family cytokines and receptors was detected by
real time quantitative PCR in resting and activated peripheral blood mononuclear cells
(PBMCs), T cells, B cell, natural killer cells (NK cells), monocytes, mast cells, and
dendritic cells. Their results showed that while monocytes are the major cellular sources
for IL-19 and IL-20, a variety of activated immune cells, including monocytes, PBMCs,
dendritic cells, and T cells, express IL-10, IL-24, and IL-26; the expression of IL-22 is
restricted to activated T cells and mast cells.
For the receptors, IL-10R1 and IL-10R2 were expressed ubiquitously in all the
immune cell types examined, indicating hematopoietic cells are the target cells for IL-10.
Interestingly, Malefyt group found that while a low expression level of IL-20R2 was
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observed in hematopoietic cells, no expression of IL-20R1 or IL-22R1 was detected in
any of the immune cell types, indicating the IL-20 subfamily members, including IL-19,
IL-20, IL-22, IL-24, and IL-26, would not be biologically active in hematopoietic cells
(Nagalakshmi et al., 2004). However, by examining a panel of stromal and epithelial
tumor cells lines, they found that IL-20R1, IL-20R2, and IL-22R1 are highly expressed in
epithelial and stromal tissues. Therefore, they concluded the IL-20 subfamily cytokines
are produced by immune cells and act on epithelial and stromal cells, bridging the
communication between the immune cells and epithelial/stromal cells.
Sabat group further confirms and expands the knowledge of the expression
patterns and targets of the IL-20 subfamily cytokines (Kunz et al., 2006). They found
that IL-19, IL-20, and IL-24 were not only produced by activated monocytes, but also by
keratinocytes to a similar extent. In vivo studies demonstrated that these cytokines are
preferentially induced in inflammatory tissues. They demonstrated that all the immune
cells express IL-20R2, albeit at a lower level compared with IL-10R1 and IL-10R2; the
expression of IL-20R1 and IL-22R1 is absent from either resting or LPS activated
macrophages, DCs, or other immune cells. In conclusion, IL-10, as a major antiinflammatory and immunosuppressive cytokine, is exclusively produced by and acts on
a variety of immune cells. IL-19, IL-20, and IL-24 can be produced by both immune cells
and tissue cells, but only exert their functions on epithelial and tissue cells. IL-22
produced by T cells and IL-26 produced by both monocytes and T cells mediate their
effects on epithelial and tissue cells as well (Fig. 14).
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Figure 14 The cellular sources and targets of the IL-10 family
cytokines. (Sabat, 2010)

Interleukin-24
In humans, when the MDA-7 gene encodes a protein with an abnormal long
signal peptide, it will not be secreted into extracellular space. When the gene encodes a
protein with a shorter canonical signal peptide, the protein can be secreted outside the
cells and mediates its function through membrane bound receptors. MDA-7 was
renamed IL-24 due to its cytokine property (Caudell et al., 2002). The nascent IL-24
protein possesses a long leader sequence to guide the protein into endoplasmic
reticulum (ER) for secretion. The leader sequence contains 48 amino acids compared to
the conventional 19-22 amino acids in other cytokines. Therefore, IL-24 in extracellular
space is actively secreted instead of being a byproduct of cell lysis (Sieger et al., 2004).
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It is reported that the mature IL-24 protein is heavily glycosylated (Caudell et al., 2002;
Mhashilkar et al., 2001). In human cell lines, the secreted IL-24 shows a molecular
weight of 40 kDa, higher than the intracellular protein with 30/23 kDa. There are three
potential N-glycosylation sites in the coding region of IL-24 (Caudell et al., 2002). When
MDA-7 protein was treated with glycopeptidase F, an endoglycosidase that cleaves
asparagine-linked oligosaccharides at the protein backbone, western blot analysis
showed two bands, one at ~23kDa and the other at 18 kDa. When the protein was
digested for a longer period time, only one band at 18 kDa was detected, demonstrating
that the size of completely deglycosylated mature protein is 18 kDa (Chada et al.,
2004b).
Human MDA-7
Since the expression of MDA-7 protein is negatively associated with the
progression and metastasis of melanoma cells (Ekmekcioglu et al., 2001; Huang et al.,
2001), MDA-7 has been extensively studied in the cancer field. It can selectively induce
apoptosis in cancer cells, leaving normal cells unaffected (Ekmekcioglu et al., 2001;
Huang et al., 2001; Jiang et al., 1996; Madireddi et al., 2000; Mhashilkar et al., 2001;
Saeki et al., 2000; Su et al., 1998). MDA-7 has to be expressed inside cancer cells to
induce apoptosis. The induction of apoptosis is related to the upregulation of Bax
protein, independent of p53 or retinoblastoma protein (RB) (Jiang et al., 1996; Su et al.,
1998). MDA-7 proteins accumulate in the ER and Golgi compartments, cause “ER
stress”, and subsequently induce apoptosis (Breckenridge et al., 2003; Pahl, 1999).
Also, MDA-7 can cause G2/M cell cycle arrest to prevent tumor cells from entering S
phase (Ekmekcioglu et al., 2001; Mhashilkar et al., 2001). The induction of reactive
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oxygen species (ROS) in cancer cells has been demonstrated as one of the MDA-7
functions. MDA-7 induces ROS production in mitochondria, thereby causing the release
of cytochrome c and loss of mitochondrial transmembrane potential (Breckenridge et al.,
2003; Pahl, 1999). In addition, MDA-7 can suppress neovascularization by inhibiting the
production of vascular endothelial growth factor (VEGF) in cancer cells (Lebedeva et al.,
2007; Ramesh et al., 2003; Sarkar et al., 2007). The mechanisms involved in the anticancer effects of MDA-7 are summarized in Fig. 15.
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Figure 15 The mechanisms of MDA-7/IL-24 induced apoptosis in
cancer cells. (Dash et al., 2010)

Secreted IL-24 is also reported to have anti-cancer effects. It can bind to its
receptors to induce cancer-selective cytotoxicity, which is named as an antitumor
bystander function of the secreted protein (Chada et al., 2004a). The engagement of
secreted IL-24 with its receptors in endothelial cells has been implicated in mediating
anti-angiogenesis in cancer tissues (Ramesh et al., 2003). The remarkable effects of IL24 on cancer cells lead to its evaluation in several clinical trials. In the first clinical trial,
IL-24 gene was carried by adenoviruses and directly injected into tumor tissues of
patients with advanced carcinoma (Cunningham et al., 2005; Tong et al., 2005). The
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results showed that patients tolerated the injection well. IL-24 was expressed in the
injected sites and significantly induced apoptosis in cancer cells. The clinical trials found
that the mechanisms of IL-24 function in cancer cells included: induction of apoptosis,
antitumor bystander effects, and immune modulation. However, the anti-tumor effect did
not last and required repeated IL-24 injections. The clinical trials demonstrated
promising results in the application of IL-24 in cancer therapy. However, more research
is needed to improve its clinical effects.
Rat c49a/mob-5
In the rat system, two independent groups identified a gene highly homologous to
human MDA-7, named as c49a and mob-5 respectively (Soo et al., 1999; Zhang et al.,
2000). The gene shares 78% similarity at cDNA level and 68% similarity at amino acid
level with human MDA-7 (Soo et al., 1999) (Table 3). The expression of c49a was first
reported to be elevated in the leading edge during wound repair. This upregulation was
rapid, reaching a peak level within 12-24h, and gradually declining to the baseline level
by 14 days (Soo et al., 1999). Spindle-shaped fibroblast-like cells at the wound edge
were the major cell types responsible for c49a production. Since elevated c49a protein
expression was associated with the proliferation phase of wound repair, c49a was
believed to promote cell proliferation instead of inhibiting cell growth. Mob-5 was first
cloned as a gene directly induced by oncogenic ras (Zhang et al., 2000). The induction
depends on MAP kinase signaling pathway and can be abolished by inhibitors that
prevent ras protein membrane targeting. However, mob-5 was only expressed in ras
transformed cells, not in non-transformed cell even with the activation of ras signaling.
Furthermore, mob-5 receptors can also be directly induced by oncogenic ras in
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transformed cells. This coordinated upregulation of both ligands and receptors by ras
oncogene indicates that mob-5 may act on its receptors in an autocrine or paracrine
manner to promote cell growth and facilitate cell transformation.
Clearly, rat c49a/mob-5 gene mediates cell proliferation and transformation,
whereas human MDA-7 gene has been found to induce apoptosis selectively in cancer
cells. The functional discrepancy between these two genes raised a question: how
conserved is the gene between species? To answer this question, Liang et al. designed
a study to compare the genomic structure and signaling pathway between human MDA7 and rat c49a/mob-5 (Wang et al., 2004). They found that rodent and human IL-24
genes are truly homologous genes. Both rodent and human IL-24 genes are localized in
genomic loci that contain clusters of IL-10, IL-19, IL-20, and IL-24 genes with the same
gene arrangement. In addition, both rodent and human IL-24 genes have six exons and
five introns, and share conserved exon-intron junctions. The similar coding regions
between the two species generate proteins with high sequence homology. Although
rodent and human secreted IL-24 are differentially glycosylated, rat mob-5 protein can
bind to human IL-24 receptor complex and activate JAK/STAT signaling pathway to
promote cell survival and growth (Wang et al., 2004). More importantly, the expression
of human IL-24 receptors can be induced by oncogenic ras in human colon cancer cells,
demonstrating the consistency between human and rodent IL-24 gene behaviors (Wang
et al., 2004). Therefore, human and rodent IL-24 genes are highly homologous. The
seemingly functional discrepancy only reflexes the multiple facets of IL-24 functions.
Alternatively, the homologs of the gene between species provide foundations for us to
evaluate its biological functions in rodents due to the easier genetic manipulation in
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lower class species.
Mouse FISP
The mouse IL-24 ortholog was first identified by representational difference
analysis method to isolate genes that are specifically induced by Th2 cells (Schaefer et
al., 2001). IL-4 treatment was able to induce the novel gene expression in Th2 cells
through STAT6-mediated pathway. Thus, the gene was named IL-4-induced secreted
protein (FISP). Subsequent studies revealed that the FISP gene encodes a protein of
220 amino acids with a 65-aa-long potential signal peptide sequence. Blast analysis
revealed that FISP shares 89% identity with rat mob-5/c49a and 80% identity with
human mad-7 at cDNA level; at protein level, FISP shares 93% similarity with rat mob5/c49a and 69% similarity with human mad-7 (Table 3). The induction of FISP was only
found in Th2 cell, but not Th1 cells, and required both IL-4 receptor and TCR complex
signaling. FISP was detected in the conditioned medium of long-term cultured D10.G4
cells, demonstrating it can be actively secreted outside the cells. FISP, as a secreted
cytokine in the immune system, indicates it may mediate important roles in host immune
response.
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Table 3 Conservation of the primary sequence of IL-24 protein across
species. (Wang and Liang, 2005)

IL-20R cytokines in inflammatory diseases
It is reported that the expression of IL-19, IL-20, and IL-24 (named as “IL-20R
cytokines” collectively) is increased in inflamed tissues of various diseases, such as
psoriasis, inflammatory bowel disease (IBD), and rheumatoid arthritis (RA) (Andoh et
al., 2009; Kragstrup et al., 2008; Kunz et al., 2006). Increased expression of IL-19 and
IL-20 mRNA was found in the basal and suprabasal keratinocytes in the epidermis of
80% untreated psoriatic patients, whereas IL-24 mRNA was enriched in mononuclear
inflammatory cells in the derma (Romer et al., 2003). In parallel, the expression of IL20R1, IL-20R2, and IL-22R1 was upregulated in keratinocytes of psoriatic epidermis (Sa
et al., 2007). Engagement of IL-20R cytokines with receptors activates STAT3 to induce
various downstream gene expression, including proinflammatory cytokines, such as
CXCL1, CXCL5, and CXCL7 (Boniface et al., 2005; Sa et al., 2007), genes involved in
tissue remodeling, such as MMP1, MMP3, and Kallikreins (Boniface et al., 2005; Li et
al., 2009; Liang et al., 2006; Sa et al., 2007; Wolk and Sabat, 2006), and antimicrobial
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peptides, such as S100 family genes and β-defensin (Boniface et al., 2005; Liang et al.,
2006; Sa et al., 2007; Wolk et al., 2006). Increased expression of S100A7 (also named
as psoriasin) is the characteristic feature of psoriatic skin. Romer et al. reported that the
overexpression of IL-19 and IL-20 mRNA in the skin subsided after short-term treatment
with cyclosporine A or calcipotriol in psoriatic patients (Romer et al., 2003) Transgenic
mice overexpressing IL-20R cytokines further confirm their pathogenic roles in psoriasis
(Blumberg et al., 2001) (He and Liang, 2010) (Wolk et al., 2009). IL-20, IL-22 or IL-24
transgenic mice died shortly after birth, with tight, wrinkled, and shiny skin. Histological
analysis of the skin revealed epidermal hyperplasia, compact stratum corneum, and
abnormal keratinocyte differentiation, hallmarks of psoriasis. Genetic association
studies also suggest that IL-20R cytokines are associated with the susceptibility of
psoriasis (Kingo et al., 2004; Koks et al., 2004; Koks et al., 2005). Therefore, IL-20R
cytokines play an important role in the development of psoriasis, and their up-regulation
is a characteristic feature of psoriatic skin.
IL-20R cytokines are upregulated in mononuclear cells in the synovial fluid of
patients with rheumatoid arthritis (RA) (Alanara et al., 2010; Kragstrup et al., 2008). IL24 is also detected in endothelial cells (Kragstrup et al., 2008). The receptors for IL-20R
cytokines are found to be expressed in synovial tissues, indicating the involvement of
IL-20R cytokines in RA (Kragstrup et al., 2008; Sakurai et al., 2008). Stimulation with IL19 induced IL-6 production and reduced apoptosis in synovial cells (Sakurai et al.,
2008). IL-20 promoted endothelial cell proliferation as well as proinflammatory cytokine
expression in synovial cells, such as CCL2, IL-6, and IL-8 (Hsu et al., 2006). In addition,
recombinant

human

IL-20

or

IL-24

stimulated

the

expression

of

monocyte
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chemoattractant protein 1(CCL2/MCP-1) in cultured synovial fluid mononuclear cells
(Kragstrup et al., 2008). Blockage of IL-20R cytokine signaling attenuated disease
severity in a rat animal model of collagen-induced arthritis (Hsu et al., 2006). Therefore,
IL-20R cytokines induce the expression of proinflammatory cytokines and chemokines
in RA, indicating their pathogenic roles.
In contrast to the pathogenic roles of IL-20R cytokines in psoriasis and RA,
various studies demonstrated a protective role of these cytokines in IBD. Elevated
expression of IL-20R cytokines was found in serum samples of patients with active IBD,
but not inactive IBD or healthy controls (Andoh et al., 2009; Dambacher et al., 2009;
Fonseca-Camarillo et al., 2014; Fonseca-Camarillo et al., 2013). In a distal colon culture
system, when the intestinal epithelial barrier was injured by chemical DSS to induce
colitis, colon from IL-19-/- mice elicited more proinflammatory cytokine production than
the wild type controls (Azuma et al., 2011). However, the levels of cytokines and
chemokines in the steady-state colon organ from IL-19-/- mice were not different from
wild type mice, indicating IL-19 modulates the susceptibility and disease severity of
colitis. Comparing with the unaffected regions, IL-24 expression was significantly higher
in the active regions of ulcerative colitis and Crohn’s disease (Andoh et al., 2009). The
inflammatory cytokine IL-1β facilitates the binding of transcriptional factors AP-1 and
C/EBP-β to IL-24 promoters to induce IL-24 expression in subepithelial myofibroblasts
(SEMFs). IL-24 acts on colonic epithelial cells to induce the expression of SOCS3 and
membrane-bound mucins, such as MUC1, MUC3, and MUC4, indicating IL-24 exerts
repressive and regulatory effects in mucosal inflammation in IBD (Andoh et al., 2009).
The reasons are unknown for the different roles that IL-20R cytokines play in different
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inflammatory diseases. It warrants further research in understanding the physiological
and pathophysiological roles of these cytokines in various disease models.
Suppressor of cytokine signaling (SOCS)
As has been mentioned above, excessive inflammation can cause extensive
tissue damage or autoimmune diseases. Moreover, any scar formation in the cornea
would lead to visual dysfunction. Therefore, cytokine response must be tightly regulated
to achieve a balance and restore tissue homeostasis. A negative feedback mechanism
has evolved within cells to tune the immune response to prevent destructive events.
Suppressor of cytokine signaling (SOCS) proteins are negative regulators of the
JAK-STAT signaling pathway (Dimitriou et al., 2008). The first member of the SOCS
family was identified by Yoshimura et al. in 1995 and named as cytokine-induced STAT
inhibitor (CIS) (Yoshimura et al., 1995). Subsequent studies identified other proteins
that share homologous conformation with CIS. So far, the SOCS family is constituted of
eight members: CIS and SOCS1-7 (Minamoto et al., 1997; Naka et al., 1997; Starr et
al., 1997). SOCS1 and SOCS3 are the two most studied members in the SOCS family.
All SOCS proteins contain a central SH2 domain and a SOCS box (Babon et al., 2009;
Zhang et al., 1999) (Fig. 16). Because of the SH2 domain, any tyrosine phosphorylated
signaling protein (p-receptor, p-JAK, or p-STAT) is a conceivable substrate. The SH2
domain acts as an adaptor to recruit ubiquitin ligases to the phosphorylated signaling
proteins, facilitating their degradation. SOCSs bind to the E3 complex through the
conserved SOCS box. SOCSs are also pseudo-substrate inhibitors for JAKs and their
STAT proteins, thereby terminating signal transduction (Dimitriou et al., 2008).
Additionally, SOCS1 and SOCS3 have a kinase inhibitory region that can inhibit JAKs
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directly (Sasaki et al., 1999; Yasukawa et al., 1999). While SOCS1 negatively regulates
STAT1 activation in the IFN-γ signaling pathway, SOCS3 is a major inhibitor in the
STAT3 signaling cascade (Kubo et al., 2003; Yoshimura et al., 2007).
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Figure 16 The structure and functions of the SOCS family. (A) The
proteins of the SOCS family all contain a SH2 domain and a SOCS box.
Additionally, SOCS1 and SOCS3 have a kinase inhibitory region (KIR). (B)
The SH2 domain can bind to any tyrosine phosphorylated signaling protein
(p-receptor, p-JAK, or p-STAT) and target the binding partners to
ubiquitination and proteasome degradation. SOCS proteins bind to the E3
complex through the conserved SOCS box. KIR can directly inhibit JAK
activity. (Dimitriou et al., 2008)
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The SOCS3-mediated negative feedback loop plays an important role in
maintaining tissue homeostasis, disruption of which would cause unrestrained
inflammation or increased infection susceptibility. It is reported that SOCS3 expression
is increased in inflamed human tissues, particularly in recruited leukocytes and also in
epithelia (White et al., 2011). SOCS3 expression is enhanced in both acute and chronic
inflammation, with a higher level in acute inflammation (White et al., 2011). Uto-Konomi
et al. reported that keratin 5-specific SOCS3 conditional knockout (cKO) mice displayed
epidermal hyperplasia and massive leukocyte infiltration. Further mRNA detection
revealed that the expression of IL-1β, IL-4, IL-6, IL-19, IL-20, and IL-24 was increased in
SOCS3 cKO skin tissue. The authors concluded that SOCS3 negatively regulates
STAT3 hyper-activation to prevent skin inflammation (Uto-Konomi et al., 2012).
SOCS3 expression is not only stimulated by cytokines, but also by pathogen
components that activate the innate immune response (Carow and Rottenberg, 2014).
Some pathogens have evolved to induce the expression of SOCS3 to suppress host
inflammatory response, facilitating their invasion in the host. It is known that several
viruses can stimulate SOCS3 expression, such as human respiratory syncytial virus
(RSV) (Hashimoto et al., 2009), hepatitis C virus (Collins et al., 2014), herpes simplex
virus (Yokota et al., 2005), and Epstein-Barr virus (Michaud et al., 2010). It is believed
that increased SOCS3 expression suppresses type I IFN production, and hence
attenuates the anti-viral response (Carow and Rottenberg, 2014). Silencing of SOCS3
by siRNA inhibits viral replication (Hashimoto et al., 2009; Yokota et al., 2005). The
roles of SOCS3 in bacterial and parasitic infections are less clear and warrant more
research. Enhanced SOCS3 expression in myeloid cells conveyed resistance to M.
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tuberculosis through the regulation of the IL-6/STAT3 signaling pathway (Carow et al.,
2013). SOCS3fl/fl lck cre mice showed increased susceptibility to Leishmania major due
to over-production of the anti-inflammatory cytokines IL-10 and TGF-β. On the other
hand, SOCS3 transgenic mice (Lck-SOCS3 Tg mice) that over express SOCS3 in T
cells also succumbed to L. major infection because of the increased IL-4 secretion
(Kinjyo et al., 2006; Nakaya et al., 2011). Therefore, SOCS3 expression must be tightly
regulated in infection scenarios to ensure a favorable outcome.
Central hypothesis
Our central hypothesis is that IL-24 is an early response cytokine that modulates
corneal innate immune response and involved in the pathogenesis of microbial keratitis
in a SOCS3 related manner. This hypothesis will be tested with three specific aims:
Aim 1: To characterize the expression of IL-24 and SOCS3 in the cornea in
response to PA infection. Experiments in this aim will identify the expression pattern of
IL-24 and SOCS3 in mouse corneal epithelial cells as well as whole cornea after PA
infection in vivo. We will also determine the expression of IL-24 receptors in the cornea
to identify IL-24 targeted cells. By using MyD88-/- mice, we will explore whether the
expression of IL-24 and SOCS3 is MyD88 dependent.
Aim 2: To evaluate the functions of IL-24 and SOCS3 in PA keratitis. The
experiments in this aim will explore the roles that IL-24 and SOCS3 play in corneal
innate immunity in response to PA infection by using siRNA, recombinant protein, and
receptor blockage approaches. Endpoints include the clinical outcome, bacterial
clearance, and cellular infiltration. Moreover, we will determine how loss and gain of
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function of IL-24 modulate the expression of pro- and anti-inflammatory cytokines in the
cornea.
Aim 3: To explore the regulatory relationship of IL-24 and SOCS3 in vitro with
primary human corneal epithelial cells (HCECs). Experiments in this aim will use heatkilled PA to challenge primary HCECs to determine whether IL-24 is also induced in
HCECs upon PA challenge. In addition, we will use recombinant proteins to treat cells to
explore the cytokine regulation network.
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CHAPTER 1: CHARACTERIZE THE EXPRESSION OF IL-24, ITS RECEPTORS, AND
SOCS3 IN THE CORNEA IN RESPONSE TO P. AERUGINOSA INFECTION.
Summary
We propose that PA induces early expression of IL-24 and SOCS3 in the cornea
through MyD88 signaling pathway, and IL-24 targets corneal epithelial cells. Our cDNA
array results demonstrate that IL-24 and SOCS3 are induced at the early stage of PA
infection (6hpi) in corneal epithelial cells. PA activates TLRs in corneal epithelial cells.
The signal may be transduced through MyD88 to directly induce early IL-24 expression.
As SOCS3 is a downstream negative regulator of IL-24, SOCS3 would share a similar
expression pattern with IL-24. Since both Malefyt’s and Sabot’s groups reported that IL24 receptor chains are absent in immune cells (Kunz et al., 2006; Nagalakshmi et al.,
2004), IL-24 may exert its function primarily in corneal epithelial cells.
In this study, we used the needle scratch model to induce PA infection in B6
mouse cornea. Our cDNA microarray results show that IL-24 and its downstream
negative regulator SOCS3 are differentially regulated by flagellin pretreatment. Since
flagellin pretreatment is known to induce profound innate immune protection, downregulation of IL-24 and SOCS3 implies negative effects of IL-24 and SOCS3 on the
outcome of microbial keratitis. To define the role of the IL-24-STAT3-SOCS3 signaling
pathway in PA keratitis, it is of importance to first verify the expression patterns of IL-24
and SOCS3, as well as the IL-24 receptor subunits at both mRNA and protein levels. By
using quantitative PCR analysis, we confirmed that elevated expression of IL-24 and
SOCS3 in response to PA infection was dampened by flagellin pretreatment.
Furthermore, time course study in whole corneal extracts demonstrated that the
expression pattern of SOCS3 follows the same kinetics as that of IL-24, indicating the
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correlation of IL-24 and SOCS3. The expression of both IL-22R1 and IL-20R2 was
detected in corneal epithelial cells, demonstrating IL-20R cytokines target corneal
epithelial cells. The absence of IL-20R2, the common chain of the receptor complex, in
bone marrow derived macrophages indicates IL-20R cytokines may not act on
macrophages. By recruiting the adapter protein MyD88, TLR signals are transduced into
nucleus to activate inflammatory response to combat pathogen invasion (Kawai and
Akira, 2007). Our results demonstrate that MyD88 plays an important role in generating
inflammatory response in the cornea in response to PA infection. MyD88 signaling
pathway accounts for the majority of the induction of IL-24 and SOCS3 at the early
stage of infection.
Introduction
The corneal epithelial layer forms the first line of defense against pathogens.
TLRs recognize bacterial components to induce pro-inflammatory and anti-inflammatory
cytokine expression in an attempt to clear pathogens (Pearlman et al., 2008). MyD88 is
a convergent adaptor for many TLRs, including TLR4 and TLR5. Activation of MyD88
eventually results in phosphorylation of NF-κB, which would be translocated into the
nucleus to promote the expression of cytokines and chemokines (Kawai and Akira,
2007). A certain amount of inflammatory response is beneficial to pathogen clearance;
however, prolonged unrestrained inflammation is devastating and contributes to corneal
destruction (Thakur et al., 2002). Therefore, the TLR-mediated inflammatory response
must be precisely regulated.
IL-1β is the major inflammatory cytokine in response to infection. Signaling via
TLRs can directly induce IL-1β expression, which can act as a chemokine to recruit
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immune cell infiltration (Karmakar et al., 2012; Rudner et al., 2000). Neutrophils can
further produce a large amount of IL-1β, resulting in a cascade of inflammation
(Karmakar et al., 2012). In response to infection, γδ T cells can produce IL-17A, another
important chemokine to recruit neutrophils (Cho et al., 2010). Matrix metalloproteinase
13 (MMP13) is an enzyme that participates in collagen degradation. MMP13 is
considered to be an important inflammatory cytokine since it can facilitate pathogen
dissemination (Gao et al., 2015). Besides the inflammatory cytokines, TLR signaling
also induces the expression of anti-inflammatory cytokines. IL-1 receptor antagonist (the
gene is referred as IL-1RN; the encoded protein is referred as IL-1RA) can be secreted
by epithelial cells, as well as a variety of immune cells in response to infection. It can
bind to cell surface IL-1 receptor to terminate signal transduction, functioning as a
natural inhibitor of IL-1β (Weber et al., 2010). S100A8 and A9 belong to the S100 family
of calcium-binding proteins. The heterodimer of S100A8 and A9 (also referred to as
calprotectin) plays critical roles in innate immunity since it can prevent the growth of
bacteria, fungi, and protozoa by chelating Mn+2 and Zn+2 ions (Clark et al., 2016;
Clohessy and Golden, 1995; Damo et al., 2013; Sohnle et al., 2000). Besides their
antimicrobial properties, S100A8/A9 are also associated with inflammation, as
evidenced by their high expression levels in psoriasis (Sa et al., 2007).
Our previous studies showed that pretreatment of mouse corneas with flagellin,
which signals through TLR5, can protect mouse corneas from PA infection (Kumar et
al., 2010; Kumar et al., 2008; Yoon et al., 2013). We found that this flagellin-induced
protection is due to the reprograming of gene expression in epithelial cells to enhance
the innate defense against invasive pathogens (Gao et al., 2013). Our genome-wide
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cDNA microarray showed that the expression of IL-24 and its downstream negative
regulator, SOCS3, was notably upregulated in response to infection and significantly
suppressed by flagellin pretreatment (Gao et al., 2013).
Increased expression of IL-19, IL-20, and IL-24 (IL-20R cytokines) was found in
various inflammatory tissues, such as the skin of psoriasis, and the mucosa of IBD
patients, indicating these cytokines may play an important role in inflammation (Andoh
et al., 2009; Kragstrup et al., 2008; Kunz et al., 2006). The expression of IL-19 and IL24 was increased in mouse skin in response to Methicillin-resistant Staphylococcus
aureus (MRSA), while the expression of IL-20 remained unchanged during the course of
infection (Myles et al., 2013). It is reported that a high level of SOCS3 expression was
found in the epithelia of human tissue with acute or chronic inflammation, especially with
acute inflammation (White et al., 2011). Besides, some pathogens can induce SOCS3
expression to evade the immune response (Carow and Rottenberg, 2014). However,
the expression patterns of IL-20R cytokines and SOCS3 in the cornea in response to
PA infection remain unknown.
Results
PA infection induces IL-24 and SOCS3 expression in mouse corneal epithelial
cells (CECs)
To verify the cDNA microarray results, we infected mouse corneas with 1.0×104
colony forming units (CFUs) of PA stain ATCC 19660. Corneal epithelial cells were
collected at 6hpi and subjected to PCR analysis. As shown in Figure 17A, flagellin
challenge alone slightly induced IL-24 expression relative to the naïve cornea. PAinfection increased the expression of IL-24, and this elevation of IL-24 expression was
dampened by flagellin pretreatment in B6 mouse CECs. As IL-24 shares receptors with
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IL-19 and IL-20, we explored the induction of these cytokines in response to infection.
While low levels of IL-19 were detected in all samples, no IL-20 mRNA was detected.
The infection-induced expression of SOCS3 was also dampened by the flagellin
pretreatment (Fig. 17B). The expression of IL-1β, an innate immune and major
inflammatory mediator, significantly increased after PA infection. IL-1β expression was
attenuated to an extent equivalent to the normal control, consistent with flagellininduced protective and anti-inflammatory response (Fig. 17B). There is no significant
change in IL-6 level at 6 hpi in mouse CECs, with or without flagellin pretreatment (Fig.
17B).
The induction of IL-24 and SOCS3 in mouse CECs after PA infection was further
confirmed at the protein level. Mouse CECs were collected at both 6hpi and 18hpi for
immunoblot analysis. As shown in Fig.17C and E, PA-infection induced IL-24 protein
expression as early as 6hpi. The abundance of IL-24 protein further increased at 18hpi.
The activation of STAT3 followed a similar expression pattern as that of IL-24. SOCS3
protein was detected at a later time point, 18hpi (Fig. 17D and E).
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Figure 17 P. aeruginosa (PA) infection induces IL-24 and SOCS3 expression
in B6 mouse corneal epithelial cells; Flagellin pretreatment attenuates their
expression. Mouse corneas were scratched with a needle and topically
pretreated with 500ng flagellin for 24 hours. PBS was used as control. Then the
corneas were scratched again and inoculated with PA (ATCC 19660, CFUs:
1.0X104). Cornea epithelia were collected at 6 hpi for semi-quantitative RT-PCR
(A) or quantitative real-time PCR (B) analysis of IL-24, IL-19, and IL-20 (A),
SOCS3, IL-1β, and IL-6 (B). Results are presented relative to those of naïve
corneas, set as 1. Mouse corneas were challenged with PA, then corneal epithelia
were collected at 6 hpi and 18 hpi for immunoblot analysis of IL-24 (C), SOCS3,
p-STAT3, and STAT3 (D). β-actin serves as the loading control. (E) Quantification
of protein levels based on the densitometry of the Western blots in C and D by
using the software Carestream MI SE (Informer Technologies, Inc.). P values
were generated by one-way ANOVA. Stars on top of columns are P value results
comparing with control. *P < 0.05, **P < 0.01, and ***P < 0.001. Data are
representative of three independent experiments (B: mean + s.e.m.). Flag:
flagellin. The time point in (A) and (B) was used as the same time point with the
cDNA array to confirm the cDNA array results. One more time point in (C) (18 hpi)
was used to explore the trend of protein expression level as the infection
continued.
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IL-24, SOCS3, and IL-1β are early responsive genes upon PA infection
Having shown the effects of infection and flagellin pretreatment on cytokine
expression, we then performed a time course study to compare the expression of IL-24
with IL-1β, SOCS3 and IL-6 in response to PA infection. The expression of IL-1β was
induced and detectable at 3hpi, and continued to increase gradually as the infection
progressed. Two peaks of IL-24 up-regulation were observed: a rapid and marked
increase at 3hpi, followed by a lower but significantly elevated level at 6hpi, and then a
gradual increase to a higher level at 18hpi (Fig. 18A). The expression of SOCS3
followed the observed early and late kinetics of IL-24. The expression of IL-6 started at
a later time, 9 hpi, and reached a significantly higher level at 18hpi, compared to the
naïve cornea (Fig. 18A). Hence, the infection-induced expression of SOCS3 is
correlated to that of IL-24, but not IL-6, which is also known to activate the JAK/STAT3
pathway to induce SOCS3 expression. Up-regulation of IL-19 was only detected at a
later stage of infection, 18 hpi. No elevated expression of IL-20, IL-22 or SOCS1 was
detected at all the time course studied. Significant elevation of IL-17A was detected at
18 hpi (Fig. 18A).
The expression of some of these cytokines and the activation of STAT3 were
also assessed by using Western blotting or ELISA in whole corneal extracts. Consistent
with the mRNA expression pattern, IL-24 protein expression was markedly increased at
the early stage of infection, 3 hpi, followed by a significant subsidence at 6 hpi and a
gradual increase at 9 hpi and 18 hpi. The activation of STAT3 detected by the phosphoSTAT3 level followed a similar expression pattern with that of IL-24. SOCS3 protein
expression was increased at 3 hpi and 6 hpi. The subsidence of SOCS3 protein lagged
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behind that of IL-24 and occurred at 9 hpi, followed by an increase to a higher level at
18 hpi (Fig. 18B and C). The protein levels of the inflammatory cytokines IL-1β and IL-6
increased, with higher levels observed at 18 hpi than at 9 hpi (Fig. 18D).

Figure 18 IL-24, SOCS3, and IL-1β are early responsive genes after PA
infection in B6 mouse cornea. Mouse corneas were infected with PA as in Fig.
1. Whole corneas were collected at 3 hpi, 6 hpi, 9 hpi, and 18 hpi for qPCR
analysis of IL-24, IL-1β, SOCS3, IL-6, IL-19, IL-20, IL-22, SOCS1, and IL-17A (A).
Results are presented relative to those of naïve corneas, set as 1. (B) Immunoblot
analysis of IL-24, SOCS3, p-STAT3, and STAT3 in cell lysates of the whole
corneas infected with PA for 3h, 6h, 9 h and 18 h. β-actin serves as the loading
control. (C) Quantification of protein levels based on the densitometry of the
Western Blots in B. (D) ELISA assays of IL-1β and IL-6 in cell lysates of the whole
corneas infected with PA for 9 h and 18 h. Stars on top of columns are P value
results comparing with control. *P < 0.05, **P < 0.01, and ***P < 0.001 (ANOVA).
Data are representative of three independent experiments (A and C: mean +
s.e.m.). ND: not detected.
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The receptor expression of IL-20R cytokines in mouse cornea
The expression patterns of the receptors for IL-20R cytokines remain unknown in
the cornea in response to PA infection. PCR analysis in whole corneal extracts revealed
significant decrease in the expression of the common chain IL-20R2 at 3 hpi, followed
by further decrease as the infection progressed. Significant increase of IL-22R1 was
detected at 18 hpi. There is no significant change in the expression of IL-20R1 in the
course of PA infection (Fig. 19A). Previous reports based on PCR studies demonstrated
that the receptors for IL-20R cytokines are mainly expressed in epithelial cells, but not in
immune cells (Kunz et al., 2006; Nagalakshmi et al., 2004). We further assessed the
receptor expression in protein level in membrane protein enriched fraction. Mouse
corneas were infected with PA; corneal epithelial cells were collected at 18 hpi for
immunoblot analysis of the receptors (Fig. 19C and D). While equal levels of IL-22R1
were detected in both the naïve and infected CECs at around 95 kDa, the abundance of
IL-20R2 proteins were decreased in the infected CECs, comparing with the naïve
control. The expression patterns in protein levels in CECs are consistent with the mRNA
levels in whole corneal extracts, indicating CECs may be the predominant sources of
the receptors. As in immune cells, SOCS3 is mainly produced by macrophages and is
the downstream mediator of IL-20R cytokines (Qin et al., 2012; Uto-Konomi et al.,
2012), mouse bone marrow cells were isolated and differentiated into macrophages to
evaluate the receptor expression patterns in immune cells. Flow cytometry in Fig. 19B
demonstrates the bone marrow derived cells were successfully differentiated into
macrophages, expressing both CD11b and F4/80 antigens. Immunoblot analysis shows
no bands were detected when the membrane was probed with IL-20R2 antibody,

71
whereas IL-22R1 was detected in ~60 kDa area, with a decreased expression level in
heat-killed PA challenged macrophages, comparing with the unchallenged control (Fig.
19C and D). In sum, our results confirm that IL-20R cytokines mainly act on epithelial
cells; the expression of the common IL-20R2 chain decreases in response to PA
infection in mouse CECs.
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Figure 19 The receptor expression of IL-20R cytokines in mouse cornea.
Mouse corneas were infected with PA as in Fig. 1. Whole corneas were collected at
3 hpi, 6 hpi, 9 hpi, and 18 hpi for qPCR analysis of IL-20R1, IL-20R2, and IL-22R1
(A). Results are presented relative to those of naïve corneas, set as 1. (B) Mouse
bone marrow cells were isolated and differentiated into macrophages in the
presence of mouse recombinant macrophage colony stimulating factors (M-CSF,
20 ng/ml) for 7 days. Flow Cytometry was used to analyze the expression of Mac-1
and F4/80 surface antigens to confirm the cell identity. (C) Immunoblot analysis of
IL-20R2, IL-22R1, Pan-cadherin, and Na-K ATPase in cell lysates of the corneal
epithelial cells (infected with PA for 18 h) and bone marrow derived macrophages
(challenged with heat-killed PA for 2h). Pan-cadherin and Na-K ATPase serve as
the loading control. (D) Quantification of protein levels based on the densitometry of
the Western blots in C. Relative density was based on the densitometry of Na-K
ATPase. Stars on top of columns are P value results comparing with control. *P <
0.05, **P < 0.01, and ***P < 0.001 (ANOVA). Data are representative of three
independent experiments (A: mean + s.e.m.). CECs: Corneal epithelial cells; BMM:
Bone marrow derived macrophages.
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The expression of IL-24 and SOCS3 is MyD88 dependent
Since MyD88 is a common adaptor for the membrane-bound TLRs, we used
MyD88-/- mice to evaluate whether the induction of IL-24 and SOCS3 in response to PA
infection depends on MyD88 signaling pathway. Age-match wild type and MyD88-/mice in B6 background were infected with PA in the corneas. The corneas were
examined and photographed at 18 hpi to evaluate the severity of keratitis. As shown in
Fig. 20A, around 25% of the cornea in wild type mice was inflamed and opaque.
However, the corneas in MyD88-/- mice displayed only slight cloudiness and appeared
to be comparatively less inflamed.
Whole corneal samples were collected at both 6 hpi and 18 hpi to quantify the
expression of IL-24, SOCS3, pro- and anti-inflammatory cytokines in wild type and
MyD88-/- mice (Fig. 20B). At 6 and 18 hpi, there was significantly less IL-24 and
SOCS3 in infected MyD88-/- corneas than wild type corneas. In MyD88-/- corneas, the
level of IL-24 appeared the same at 6 hpi and 18 hpi, whereas SOCS3 expression was
significantly higher at 18 hpi than 6 hpi. The inflammatory cytokines IL-1β and MMP13
were also significantly reduced in MyD88-/- corneas comparing to wild type corneas at
both time points examined. Significantly more IL-1β was observed at 18 hpi comparing
to 6 hpi in MyD88-/- corneas, whereas MMP13 expression was higher at 6 hpi than 18
hpi. As demonstrated earlier, no significant elevation of IL-6 or IL-17 was detected at 6
hpi in wild type corneas. At 18 hpi, their expression was significantly lower in MyD88-/corneas compared to wild type corneas. Elevated expression of IL-1RN and S100A8/A9
was observed in infected wild type corneas at 6 hpi, with significantly higher level at 18
hpi. Although there was no significant decrease of IL-1RN at 6 hpi in MyD88-/- corneas,
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less IL1-RN was detected at 18 hpi in MyD88-/- corneas than wild type mice. The
expression of S100A8 and A9 was significantly reduced in MyD88-/- corneas compared
to wild type corneas at both time points. Overall, these results demonstrate decreased
levels of IL-24, SOCS3, pro- and anti-inflammatory cytokines in MyD88-/- corneas in
response to PA infection, which correlates with less inflammation seen in MyD88-/corneas under the microscope. The expression of IL-24 and SOCS3 partially depends
upon MyD88 signaling pathway.

Figure 20 The expression of IL-24 and SOCS3 is MyD88 dependent. (A)
MyD88-/- mice in B6 background were infected with PA in the corneas. Agematch wild type B6 mice were used as control. The corneas were photographed
at 18 hpi. (B) Whole corneal samples were collected at 6 hpi and 18 hpi for PCR
analysis of IL-24, SOCS3, IL-1β, IL-1RN, S100A8, S100A9, IL-6, IL-17A, and
MMP13. Results are presented relative to those of wild type naïve corneas, set
as 1. Stars on top of columns are P value results comparing with control. *P <
0.05, **P < 0.01, and ***P < 0.001 (ANOVA). Data are representative of three
independent experiments (B: mean + s.e.m.).
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Discussion
These studies verify our cDNA results, demonstrating IL-24 and SOCS3 are
induced by PA infection and the elevated expression is dampened by flagellin
pretreatment in mouse CECs. Among the IL-20 subfamily cytokines, IL-24 is the early
responsive gene in mouse cornea in response to PA infection; IL-19 appears late in the
course of infection; no elevated IL-20 or IL-22 was detected in the cornea post PA
infection. The expression of both R1 and R2 receptor chains in CECs suggests that IL24 mainly acts on these residential cells.
Our previous studies demonstrate that flagellin pretreatment is able to protect
mouse corneas from bacterial or fungal infection (Gao et al., 2011; Kumar et al., 2010;
Kumar et al., 2008; Liu et al., 2014; Yoon et al., 2013). Theoretically speaking, flagellin
can be used as a prophylactic agent to prevent potential microbial infection in high-risk
individuals, such as patients who have scratched corneal epithelia after contact lens
wear. However, flagellin, as a protein, would promote antibody production to neutralize
its effects. In addition, the effects and side effects of repeated application on the ocular
surface have not yet been tested (Campodonico et al., 2010; Prince, 2006). In order to
take advantage of flagellin-induced protection for therapeutic purposes, we investigate
the genes that are differentially regulated following flagellin pre-treatment, harboring the
thoughts to find potential therapeutic reagents to control infection and inflammation.
Innate immunity forms the first line of defense upon pathogen invasion. TLRs
detect pathogen components and recruit MyD88 adaptor to mount immune response to
combat pathogens (Kawai and Akira, 2007). The corneas in MyD88-/- mice developed
less inflammation during the early stage of infection, demonstrating the critical role of
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MyD88 in response to corneal infection. Our study is consistent with the previous report
stating that reduced intraocular inflammation was observed in MyD88-/- mice with B.
cereus endophthalmitis, comparing to wild type B6 mice (Parkunan et al., 2015).
Infected MyD88-/- corneas produced significantly less pro-inflammatory cytokines, such
as IL-1β, MMP13, IL-6, IL-17A, and less anti-microbial molecules, such as IL-1RN,
S100A8 and A9, than infected wild type corneas in an early stage of infection. The
expression of IL-24 and SOCS3 also depends on MyD88 signaling pathway, as less IL24 and SOCS3 were detected in MyD88-/- corneas. Significantly elevated expression of
IL-24 and SOCS3 in infected MyD88-/- corneas compared to naïve corneas
demonstrates that other pathways may be involved in the induction of IL-24 and
SOCS3.
While the expression of IL-1β in response to infection increased with time, at the
mRNA level, IL-24 had two peaks: one at the early stage of infection, 3 hpi, followed by
a subsidence at 6h, and then a gradual increase to another peak at 18hpi. Gradual
increase in IL-1β expression may be related to the increased inflammatory response
and bacterial burden in the cornea. IL-1β, as the master regulator of the innate immune
response, may contribute to innate defense and inflammation. On the other hand, IL-24
may be regulated first as a downstream mediator of TLR signaling, similar to IL-1β.
Unlike IL-1β, which is capable of regulating its self-expression in a positive amplification
loop, the TLR-mediated expression of IL-24 declined within the first few hours. The rise
of IL-1β or other cytokines may stimulate the expression of IL-24, resulting in a gradual
increase following the initial elevation. Elevated levels of IL-24 may balance the strong
inflammatory response of the corneas as infection progresses.
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IL-20 subfamily members share the JAK/STAT3 pathway with IL-6. In our study,
PA infection induced early expression of IL-24 in mouse cornea. The mRNA expression
of IL-6 was not detected until a later time (9 hpi) in the course of PA infection. Activation
of STAT3 was detected at an early time point, corresponding to the expression of IL-24.
We suggest that the early activation of STAT3 is due to the expression of IL-24. Lack of
elevated SOCS1 expression in infected corneas demonstrates that SOCS3 is the major
downstream mediator of IL-20R cytokine signaling pathway in mouse cornea.
Expression of both IL-22R1 and IL-20R2 was observed in mouse corneal
epithelial cells, indicating IL-20R cytokines target corneal epithelial cells. Andoh et al.
also reported that IL-20R1, IL-22R1, and IL-20R2 are expressed in epithelial cells from
both normal colonic mucosa and colonic mucosa with IBD (Andoh et al., 2009).
Decreased expression of IL-20R2 in infected corneas may reflect feedback inhibition of
receptor expression due to the massive production of ligands, which would be IL-24
and/or IL-19. Lower molecular size of IL-22R1 in macrophage extracts (60 kDa
comparing to 95 kDa in corneal epithelial extracts) indicates that the receptor may be
chemically modified differently between the two cell types. No IL-20R2 was detected in
macrophage extracts with or without heat-killed PA challenge, indicating that IL-20R
cytokines cannot target macrophages. Our study is consistent with Carollo and
colleagues’ report showing that R1 receptors for IL-20R cytokines have a wide
expression pattern, whereas IL-20R2 expression is more restricted to certain cell types
(Blumberg et al., 2001). However, by using PCR analysis of a wide range of immune
cells, both Malefyt and Sabat group demonstrated that no expression of IL-20R1 or IL22R1 in immune cells; IL-20R2 was expressed at a low level in immune cells (Kunz et
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al., 2006; Nagalakshmi et al., 2004). The reason for the disparity of these studies is
unknown and warrens more research. Nevertheless, a common conclusion can be
reached that IL-20R cytokines do not act on immune cells.
In summary, we demonstrate that IL-24 is an early responsive gene in mouse
cornea post PA infection. The expression pattern of SOCS3 correlates with that of IL24, indicating it may mediate the downstream effect of IL-24. The induction of both IL-24
and SOCS3 partially depends on MyD88 signaling pathway. The restricted expression
of receptors on corneal epithelial cells indicates IL-24 acts on corneal epithelial cells,
but not immune cells.
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CHAPTER 2: EVALUATE THE FUNCTIONS OF IL-24 AND SOCS3 IN PA
KERATITIS.
Summary
We have shown that IL-24 and SOCS3 are differentially regulated by flagellin
pretreatment, and SOCS3 expression follows a similar pattern with IL-24. However,
their functions in PA keratitis are still unknown. We propose that early induction of
negative regulator SOCS3 by IL-24 would impair the innate defense against PA
infection. At the early stage of infection, pathogens induce the expression of AMPs and
chemokines, which would recruit immune cells, mainly neutrophils in the case of PA
infection, to the infection sites. Both AMPs and neutrophils are critical to clear
pathogens. Early induction of the negative regulator may hamper the innate defense
and hence to promote PA keratitis. SOCS3 negatively regulates STAT family proteins,
including STAT1 and STAT3. Besides IL-20R cytokines, a number of other cytokines
and growth factors signal through the STAT pathway, such as IL-6, IFNs, and G-CSF,
etc. IL-6 is an important inflammatory cytokine, and G-CSF stimulates neutrophil
production. Therefore, loss of SOCS3 may cause STAT1/3 activation without restriction,
resulting in more inflammation in the cornea.
In this study, we first used siRNA approach to knock down IL-24 gene expression
to evaluate its function. Our results show that silencing of IL-24 reduces PA keratitis
with less bacterial burden and less neutrophil infiltration in the cornea. The less keratitis
in the silencing group may be due to the early induction of antimicrobial peptides
S100A8 and A9 in corneal epithelial cells to kill bacteria directly, resulting in less
bacteria enter the cornea to cause pathology. At a later stage of infection (1 dpi),
silencing of IL-24 dampens the expression of SOCS3, inflammatory cytokines (including
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IL-6, MMP13, IL-17A, and IL-1β), and anti-inflammatory cytokines (including IL-1RN,
S100A8 and A9, and CRAMP). Blockage of IL-20R2 with neutralizing antibody further
confirms that down-regulation of IL-24 signaling pathway improves the outcome of PA
keratitis. In addition, recombinant IL-24 was used to evaluate the gain of function of IL24 in PA keratitis. Recombinant IL-24 leads to more severe keratitis, more live bacteria
and neutrophil infiltration in the cornea. Administration of recombinant IL-24 before PA
infection further increases the expression of SOCS3, pro- and anti-inflammatory
cytokines comparing to infection alone. Their up-regulation may be due to the more
severe keratitis with recombinant IL-24 application. We also evaluated the function of
the downstream mediator, SOCS3, in PA keratitis. Silencing of SOCS3 increases the
severity of keratitis, bacterial number, and inflammation in cornea, indicating SOCS3
plays an important role in restricting inflammation and infection. Overall, we
demonstrate that IL-24 plays a detrimental role in PA keratitis, possible due to the early
induction of the negative regulator, SOCS3.
Introduction
Increased expression of IL-24 and SOCS3 has been found in many inflamed
tissues of various diseases, such as skin inflammation (e.g. psoriasis), rheumatoid
arthritis, and inflammatory bowel disease (IBD), etc.(Andoh et al., 2009; Kragstrup et al.,
2008; Sa et al., 2007; Uto-Konomi et al., 2012). It is reported that IL-24, signaling
through JAK/STAT3 and MAPK pathways, promotes the secretion of pro-inflammatory
cytokines IL-8 and MMP-1 in human epidermal keratinocytes under both endogenous
and environmental toxic stress (Jin, Choi, Chun, & Noh, 2014). Contrasting to the proinflammatory role in skin inflammation and rheumatoid arthritis, IL-24 exhibits repressive
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and regulatory role in IBD (Andoh et al., 2009). In terms of infection, IL-24 has been
documented to have protective effects against intracellular pathogens, such as
Salmonella typhimurium and Mycobacterium tuberculosis (Ma et al., 2009; Ma et al.,
2011). However, Myles and colleges demonstrated that signaling through IL-20R2
pathway promotes cutaneous infection with MRSA through the inhibition of IL-1β and IL17A production. Yet they did not directly evaluate the functions of IL-24 (Myles et al.,
2013).
Both cytokines and pathogen components can stimulate SOCS3 gene
expression (Carow and Rottenberg, 2014). Studies in different mouse models have
proven the critical importance of SOCS3 in restraining inflammation and promoting
optimal levels of protective immune response against the infection (Rottenberg and
Carow, 2014). Enhanced SOCS3 expression has been reported to convey resistant to
M. tuberculosis infection (Carow et al., 2013; Carow and Rottenberg, 2014). On the
other hand, some pathogens have evolved to modify host SOCS3 expression to evade
the immune response. For example, Epstein-Barr virus and Herpes simplex virus can
stimulate SOCS3 expression to suppress type I IFN production, thereby subverting the
host immune response (Michaud et al., 2010; Yokota et al., 2005). Demirel et al. found
that SOCS3, but not SOCS1, was induced in human bladder epithelial cells when the
cells challenged with uropathogenic E. coli. They believed that E. coli was able to
modify SOCS3 and STAT3 signaling in human bladder epithelial cells to circumvent the
host response and cause urinary tract infection (Demirel, Save, Kruse, & Persson,
2013).
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To date, the functions of IL-24 and SOCS3 in bacterial keratitis and their
regulatory relationship have not been explored. We used IL-24 siRNA and IL-20R2
neutralizing antibody to evaluate the loss of function of IL-24 signaling pathway in PA
keratitis. In addition, mouse recombinant IL-24 was used to evaluate the gain of function
of IL-24. siRNA approach was also used to evaluate the important role of SOCS3 in PA
keratitis. Our studies demonstrate that IL-24 signaling pathway increases the
susceptibility of mouse cornea to PA infection. PA induces early expression of IL-24,
which readily induces SOCS3 expression, resulting in suppression of the necessary
immune response to combat infection at an early time point.
Results
Silencing of IL-24 improves the outcome of PA keratitis in mouse cornea
To determine whether IL-24 influences the host defense against PA keratitis, we
subconjunctivally injected B6 mice with IL-24 siRNA, with non-specific siRNA as the
control. Western blotting analysis of the whole corneas at 1 dpi revealed an effective
knockdown of IL-24 mRNA by siRNA, as well as the downregulation of STAT3
activation (Fig. 21A and B).
The progress of PA keratitis in the control siRNA and IL-24 siRNA treated
corneas was monitored for 3 days. Micrographs taken daily showed that knocking down
IL-24 attenuated the severity of keratitis, compared to the control group, at all three
days examined (Fig. 21C). At 3 dpi, the control corneas developed severe keratitis, thick
opacity covering the whole cornea, and surface irregularity; while the corneas injected
with IL-24 siRNA had moderate keratitis with lighter opacity located at the center of the
cornea (Fig. 21C). The severity of keratitis was quantitated with a 12-scale clinical score
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system by evaluating the area and density of opacity and surface irregularity (Wu et al.,
2003). The clinical scores assigned to IL-24 silencing mice were significantly lower than
those of their control counterparts (Fig. 21D). Mice were sacrificed at 3dpi and whole
corneas were subjected to bacterial counting and MPO measurement to evaluate
neutrophil infiltration. Silencing of IL-24 resulted in lower bacterial burden and reduced
influx of neutrophils compared to the control corneas (Fig. 21E and F).
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Figure 21 Silencing of IL-24 attenuates the severity of PA infection in
mouse cornea. Mice were subconjunctivally injected with IL-24 siRNA
(10μM/μl, 5ul) twice in two days. Corneas were inoculated with PA 6h after the
second injection. Non-specific siRNA serves as control. (A) Immunoblot analysis
of IL-24, p-STAT3, and STAT3 in cell lysates of IL-24 siRNA- or control siRNAtreated corneas at 1 dpi. β-actin serves as the loading control. (B) Quantification
of protein levels based on the densitometry of the Western blots in A. (C) Mice
were monitored and photographed daily up to 3 dpi. (D) Clinical scores were
assigned to each cornea daily and plotted as median + interquartile range. At 3
dpi, the corneas were excised and subjected to bacterial plate counting (E) and
MPO assay (F). P values were generated by Man-Whitney test (D) or unpaired
student t test (B, E and F). *P < 0.05, **P < 0.01 and ***P < 0.001. Data are
representative of three independent experiments with five mice per group (B, E
and F: mean + s.e.m.).
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Since there was basal expression of IL-24 detected at the protein level, we
treated the corneas with IL-24 siRNA and assessed its effects on the expression of
several antimicrobial peptides (AMPs) and cytokines at 6 hpi in mouse CECs. As shown
in Fig. 22A, without the infection, the expression of the AMP S100A8 increased 3 folds
(P<0.05, ANOVA) after IL-24 knockdown. PA infection induced the expression of both
S100A8 and S100A9, yet silencing of IL-24 further elevated their expression in the
infected corneas. The expression of CXCL10 was also induced by PA infection, and
further increased when silencing of IL-24. The expression of SOCS3 was upregulated
after PA infection. IL-24 knockdown resulted in the downregulation of SOCS3
expression. The expression of inflammatory cytokines MMP13, IL-1β, and its natural
inhibitor, IL-1RN, was induced by PA infection. IL-24 knockdown dampened their
expression to a state similar to the control siRNA without infection in mouse CECs. No
significant expression change of Cathelicidin-related antimicrobial peptide (CRAMP) or
IL-6 was detected at 6 hpi. The expression of calprotectin and CXCL10 was further
confirmed in protein level (Fig. 22B). Basal expression of both calprotectin and CXCL10
was detected in the uninfected corneas. Consistent with the mRNA expression, the
protein expression of calprotectin and CXCL10 was induced by PA infection, and further
enhanced when knocking down of IL-24.
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Figure 22 Silencing of IL-24 upregulates the expression of antimicrobial
peptides and chemokine in mouse corneal epithelial cells in response to PA
infection. Mouse corneas were treated with IL-24 siRNA or control siRNA and
inoculated with PA as in figure 3. Corneal epithelial samples were collected at 6hpi
for qPCR (A) and ELISA (B) analysis. For q-PCR, results are presented relative to
those of control siRNA treated, uninfected corneas, set as 1. *P < 0.05, **P < 0.01,
and ***P < 0.001 (ANOVA). Data are representative of three independent
experiments with at least four corneas per group (mean + s.e.m.).
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As an early responsive cytokine, IL-24 may induce the expression of other
cytokines and/or AMPs in infected corneas. To that end, we used real-time PCR to
assess the expression of eight different genes at 1dpi in the corneas (Fig. 23A). While
most genes were unaffected by the downregulation of IL-24, the expressions of IL-1RN
(7.2 fold increase, p<0.05), S100A9 (3.3 fold increase, p<0.05), and IL-17A (0.6 fold
decrease p>0.05) were altered by IL-24 silencing. Infection induced marked
upregulation of SOCS3, IL-6, MMP13, IL-17A, IL-1β and its natural inhibitor IL-1RN,
AMP S100A8 and A9, and CRAMP at 1dpi. Knocking down IL-24 resulted in the
downregulation of the following genes: SOCS3 (1.47 fold), IL-6 (4), MMP13 (1.73), IL17A (3.3), IL-1β (3.0), IL-1RN (5.72), S100A8 (1.98) and A9 (1.45), CXCL10 (2.0), and
CRAMP (4.2 fold) (Fig. 23A). In the IL-20 subfamily, infection increased the expression
of IL-19, but not IL-20 or IL-22, at 18hpi. Silencing of IL-24 significantly dampened IL-19
expression (Fig. 23A). The expression of IL-6, IL-1β, IL-1RA, and heterodimer
S100A8/9 was confirmed at the protein level by ELISA analysis (Fig. 23B). While the
basal levels of IL-6 and IL-1β were undetected (in physiological condition, IL-6
concentration in human serum is 1-5 pg/ml (Hunter and Jones, 2015)), basal expression
of IL-1RA and S100A8/9 was observed in the control and IL-24 siRNA treated, noninfected corneas. As shown at the mRNA level, IL-6, IL-1β, IL-1RA, and S100A8/9 were
elevated at the protein level by PA infection and significantly attenuated by IL-24
silencing. The expression of SOCS3 was further confirmed in protein level. Silencing of
IL-24 downregulated SOCS3 protein expression at 1 dpi (Fig. 23C). The downregulation of the cytokines and AMPs after IL-24 silencing at 1dpi in the cornea may be
related to the diminished keratitis in the silencing group.
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Figure 23 Silencing of IL-24 dampens cytokine expression in mouse cornea
in response to PA infection. Mouse corneas were treated with IL-24 siRNA or
control siRNA and inoculated with PA as in figure 3. (A) Whole cornea samples
were collected at 1dpi for qPCR analysis. Results are presented relative to those
of control siRNA treated, uninfected corneas, set as 1. Cell lysates from whole
corneal samples at 1dpi were subjected to ELISA (B) and Western Blot (C)
analysis. (C) Blots were quantified based on the densitometry. *P < 0.05, **P <
0.01, and ***P < 0.001 (ANOVA or student T test). Data are representative of
three independent experiments with at least four corneas per group (mean +
s.e.m.) (A and B). Experiment was performed once. (C) ND: not detected.

Blockage of IL-20R2 decreases the severity of PA keratitis in mouse cornea
Next, we assessed the effects of blocking IL-20R2, the common receptor chain
for IL-19, IL-20, and IL-24, to further verify the effect of the IL-24 signaling pathway on
PA keratitis (Fig. 24). While the IgG control corneas developed keratitis gradually within
3 days, the anti-IL-20R2 antibody-treated corneas had slight corneal cloudiness at day
1, which progressed to cloudy corneas at day 2, and surprisingly resolved to cloudiness
with the outline of the iris and pupil discernable at day 3 (Fig. 24A). Clinical scoring
revealed that the anti-IL-20R2 group started with a lower score at day 1, increased the
score with a slope similar to that observed in the IgG control group at day 2, with scores
significantly lower than the control IgG treated ones at day 3 (Fig. 24B). The blockage of
IL-20R2 reduced the bacterial burden and MPO units in the corneas at 3 dpi as well
(Fig. 24C and D).
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Figure 24 IL-20R2 neutralizing antibody decreases the severity of PA keratitis
in mouse cornea. Mice were subconjunctivally injected with IL-20R2 neutralizing
antibody (200ng/5ul) 4h before the inoculation with PA. Mouse IgG serves as control.
(A) Mice were monitored and photographed daily up to 3 dpi. (B) Clinical scores were
assigned to each cornea daily and plotted as median + interquartile range. At 3 dpi,
the corneas were excised and subjected to bacterial plate counting (C) and MPO
assay (D). P values were generated by Man-Whitney test (B) or unpaired student t
test (C and D). *P < 0.05, **P < 0.01 and ***P < 0.001. Data are representative of two
independent experiments with five mice per group (D and E: mean + s.e.m.).
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Recombinant IL-24 increases the susceptibility of mouse cornea to PA infection
As a complementary approach, we assessed the effects of recombinant IL-24 on
the severity of PA keratitis. Subconjunctival injection of recombinant mouse IL-24 four
hours prior to PA inoculation resulted in more severe keratitis than that of the control
with 0.1% BSA injection (Fig. 25A). The control corneas were lightly covered (30%) at
day 1, 80% covered at day 2, and fully covered at day 3 with opacity. Surface
irregularity was also apparent at day 3. In recombinant IL-24-treated corneas, there was
a sign of central melting at day 1, central ring with heavy opacity at day 2, and heavy
opacity covered the entire cornea with corneal ulceration and neovascularization
present at day 3, pathologies usually seen in the control corneas at day 5 (Fig 25A).
The clinical scores revealed significantly higher disease severity in the recombinant IL24-treated group than that observed in the BSA control group (Fig. 25B). A single dose
of recombinant IL-24 resulted in significantly higher bacterial burden and neutrophil
infiltration than in the BSA control group at 3 dpi (Fig. 25C and D).
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Figure 25 Recombinant IL-24 increases the susceptibility of the
mouse cornea to PA infection. Mice were subconjunctivally injected with
either recombinant mouse IL-24 (200ng in 5ul 0.1% BSA) or 0.1% BSA as
control. Mouse corneas were inoculated with PA 4 h after the injection of
recombinant IL-24. (A) The infected corneas were photographed daily. (B)
The severity of keratitis was assessed with clinical scores. At 3 dpi, the
corneas were excised and subjected to bacterial load (C) and MPO unit
determination (D). P values were generated by Man-Whitney test (B) or
unpaired student t test (C and D). *P < 0.05 and **P < 0.01. Data are
representative of three independent experiments with five mice per group
(B: median + interquartile range; C and D: mean + s.e.m.).
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The expression of the same set of genes tested in IL-24 downregulated corneas
was also assessed in recombinant IL-24-treated corneas (Fig. 26). In non-infected
corneas, recombinant IL-24 triggered significant upregulation of IL-17A (4.8 fold
increase, p<0.01); while the expression of IL-1RN (2.5 fold decrease, p<0.01) and
S100A8 (0.5 fold decrease, p>0.05) was downregulated, contrasting those of IL-24
siRNA-treated corneas. The presence of recombinant IL-24 significantly augmented the
infection-induced expression of these genes, except IL-19. Administration of
recombinant IL-24 before PA infection did not significantly upregulate IL-19 expression.
No significantly elevated expression of IL-20 or IL-22 was detected with or without
exogenous IL-24 application before PA infection.
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Figure 26 Recombinant IL-24 enhances cytokine expression in mouse cornea
in response to PA infection. Mouse corneas were treated with recombinant
mouse IL-24 or 0.1%BSA and inoculated with PA as in figure 6. Whole cornea
samples were collected at 1dpi for qPCR analysis. Results are presented relative to
those of 0.1% BSA treated, uninfected corneas, set as 1. *P < 0.05, **P < 0.01, and
***P < 0.001 (ANOVA). Data are representative of three independent experiments
with at least four corneas per group (mean + s.e.m.).
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Silencing of SOCS3 impairs the control of PA infection in mouse cornea
Having shown that SOCS3, an intrinsic negative regulator to the STAT3 pathway,
was expressed in infected corneas in an IL-24 related manner, we next investigated the
effects of SOCS3 on the host response to PA infection in B6 mouse corneas using a
siRNA approach. Western blotting demonstrated the suppression of infection-induced
SOCS3 expression by SOCS3 siRNA at the protein level at 1 dpi (Fig. 27A). Both pSTAT3 and STAT3 levels were upregulated when silencing of SOCS3 (Fig. 27B).
Downregulation of SOCS3 resulted in an increase in the susceptibility of mouse corneas
to PA infection, compared to the control siRNA-treated corneas (Fig. 27C). Clinical
scores assigned to the SOCS3 silencing group were significantly higher than those
observed in the control group (Fig. 27D). Mice were sacrificed at 3 dpi to assess
bacterial burden and MPO units in the cornea. Silencing of SOCS3 resulted in
significantly higher bacterial burden and more infiltrated neutrophils in mouse corneas
than the control (Fig. 27E and F).
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Figure 27 Silencing of SOCS3 renders mouse corneas more susceptible to PA
infection. Mice were subconjunctivally injected with SOCS3 siRNA or control
siRNA, followed by PA inoculation as in Fig. 3. (A) Immunoblot analysis of SOCS3
in cell lysates of the whole cornea at 1dpi to ensure knockdown efficiency. (B)
Immunoblot analysis of p-STAT3 and STAT3 in cell lysates of the whole cornea at
1dpi. β-actin was used as a loading control. Blots were quantified based on the
densitometry. (C) The infected corneas were photographed daily. (D) The severity
of keratitis was quantitated with clinical scores. Bacterial load (E) and neutrophil
infiltration (F) were measured at 3 dpi. *P < 0.05, **P < 0.01 and ***P < 0.001 (ManWhitney test or unpaired student t test). Data are representative of three
independent experiments with five mice per group (D: median + interquartile rang;
B, E and F: mean + s.e.m.) (A, C-E). Experiment was performed once (B).

97
Discussion
In this part of the study, we demonstrated that silencing of IL-24 with siRNA
alleviated the severity of PA infection and recombinant IL-24 protein aggravated the
infection. The expression of AMP S100A8 and A9 was increased in epithelial and whole
corneal samples by silencing of IL-24 alone, whereas recombinant IL-24 had opposite
effect. PA infection induced S100A8 and A9 expression; however, their expression
further increased in the epithelia at the early time point (6 h) post infection when IL-24
was silenced. These data demonstrate that silencing of IL-24 may directly or indirectly
regulate the expression of S100A8 and A9, which may kill bacteria directly and account
for the reduced keratitis seen at the later time points of infection. As the infection and
inflammation progress, cytokine expression may be more related to the severity of
keratitis, as demonstrated by the subsidence of the cytokines and antimicrobial peptides
after IL-24 silencing at 1dpi, as less keratitis developed in the silencing group;
conversely, their expression levels at the same time point further elevated with
exogenous IL-24 administration prior to the infection.
PA is still mainly located in the corneal epithelial layer at 6 hpi. At 1 dpi, PA
invades into corneal stroma and causes majority of epithelial cell death. The major cell
type in the cornea is infiltrating cells. Therefore, the different expression of S100A8 and
A9 may be cell type specific between corneal epithelial cells at 6 hpi and whole corneas
at 1 dpi when silencing of IL-24.
CXCL10 is also known as interferon-γ-inducible protein 10 (IP-10). It signals
through the receptor CXCR3 to recruit immune cells, such as natural killer cells and
plasmacytoid dendritic cells to sites and infection and inflammation (Cao and Liu, 2007;
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Cole et al., 2001; Mohan et al., 2005). Besides functioning as a chemokine, CXCL10
possesses direct antimicrobial effects against pathogens (Cole et al., 2001; Yoon et al.,
2013). Our lab has demonstrated the important functions of interferons and CXCL10 in
immunity and infection, even in wound healing (Liu et al., 2014; Yan et al., 2016; Yoon
et al., 2013). By signaling through their receptors, interferon activates STAT1/3 to
regulate CXCL10 expression (Ivashkiv and Donlin, 2014). We observed PA infection
induces CXCL10 expression in mouse CECs at 6hpi; silencing of IL-24 further
augments its expression. Silencing of IL-24 induces less expression of the negative
regulator SOCS3. Without the negative regulator, interferon pathway is activated
without restriction to further induce CXCL10 expression. The increased CXCL10 in the
cornea may kill bacteria directly, contributing to less keratitis and less bacterial numbers
seen at a later time point in the IL-24 silencing group.
The effect of neutralizing antibody that neutralizes IL-20R2, the common receptor
chain in IL-24 signaling pathway, further confirmed the detrimental role of IL-24/IL-20R
cytokines in PA keratitis. The correlated expression of IL-24 and SOCS3 indicates that
the detrimental effects of IL-24 may be ascribed to its expedient induction of the
expression of the negative regulator, SOCS3. The ability of IL-24 to induce the
expression of the negative regulator is in line with the anti-inflammatory property of the
IL-10 family cytokines in general (Jones and Flavell, 2005). Indeed, the regulatory
cascade, IL-24/STAT3/SOCS3, is also reported to contribute to the suppression of
mucosal inflammation in inflammatory bowel disease (Andoh et al., 2009). In addition, it
is reported that the anti-inflammatory properties of IL-20R cytokines actually promotes
cutaneous infection with MRSA in an IL-1β and IL-17 related manner (Myles et al.,
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2013). Our study further demonstrated that IL-24 possesses immunosuppressive
activity that may diminish the host’s ability to control infection with a different
mechanism: the robust induction of SOCS3 expression at early stages of infection.
SOCS3 is an important negative regulator to maintain or restore tissue
homeostasis and is involved in a variety of diseases. Keratinocyte-specific SOCS3
conditional knockout mice developed severe skin inflammation with epidermal
hyperplasia (Uto-Konomi et al., 2012). It is reported that SOCS3 expression levels
positively correlate with the severity of inflammation, increasing when the diseases
progress and declining when the diseases subside (Chaves de Souza et al., 2013;
Maier et al., 2002). Our study also shows SOCS3 transcripts parallel with the severity of
keratitis when the mouse corneas were treated with IL-24 siRNA or recombinant IL-24
prior to infection. Recombinant SOCS3 constructed with cell penetrating signal has
been shown to inhibit inflammation and apoptosis, and protect mice from lethal doses of
enterotoxin B (SEB) or LPS (Jo et al., 2005). The fact that silencing of SOCS3
increases the severity of keratitis with greater bacterial burden in mouse corneas
indicates that SOCS3 not only hampers excessive inflammation, but also shapes the
corneal response to pathogens. Our results are consistent with previous reports
showing that myeloid or lymphoid cell specific SOCS3 knockout rendered mice more
susceptible to M. tuberculosis infection (Carow et al., 2013).
Silencing of SOCS3 increases the severity of PA keratitis. SOCS3 is the main
negative regulator of IL-6/gp130 signaling pathway, and is a direct target gene of
STAT3 (Garbers et al., 2015). IL-6 is a pleiotropic cytokine. It is reported that IL-6 can
utilize two mechanisms to mediate its biological functions: classical signaling and trans-
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signaling (Hunter and Jones, 2015). Classical signaling refers to a process in which IL-6
binds to the receptor complex consisting of membrane-bound IL-6Rα (mIL-6Rα) and
gp130 to mediate its biological effects. Since mIL-6Rα is only expressed in certain cell
types, classical IL-6 signaling occurs in a restricted numbers of cells such as certain
leukocyte subsets (Jones et al., 2011). Trans-signaling denotes that IL-6 binds to a
soluble IL-6Rα protein (sIL-6R) to form an IL-6/sIL-6R complex, which would
subsequently bind to gp-130 receptor unit in plasmid membrane to induce signal
transduction. Gp130 is ubiquitously expressed; thus IL-6 trans-signaling occurs in a
broad spectrum of cells (Peters et al., 1996; Rose-John and Heinrich, 1994). It is
believed that while the classical signaling mediates the anti-inflammatory and
regenerative effects of IL-6, IL-6 trans-signaling accounts predominantly for the proinflammatory activities of IL-6 (Scheller et al., 2011). It is reported that selective
inhibition of IL-6 trans-signaling may become a potential intervention to control
inflammatory arthritis (Nowell et al., 2009). In response to infection, both the levels of IL6 and sIL-6R are increased to mount an inflammatory response (Honda et al., 1992;
Jones et al., 2001; Novick et al., 1989). SOCS3 negatively regulates the IL-6/sIL-6R
signaling pathway to prevent destructive events. Silencing of SOCS3 renders the signal
to be transduced without constriction, therefore causing more severe PA keratitis in a
mouse model. Gp130 mutant mice generated by knock-in mutation of IL6st lose the
binding ability of the mutant gp130 to SOCS3. These mice display sustained activation
of STAT1 and STAT3 and develop unrestrained inflammation (Atsumi et al., 2002).
SOCS3 not only negatively regulates IL-6 trans-signaling pathway, but also is
induced by STAT3 to restrain neutrophil production and limit inflammation (Fielding et
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al., 2008; Lee et al., 2002). Silencing of SOCS3 may facilitate the G-CSF signal
transduction in bone marrow granulocytic progenitor cells to increase neutrophil
production, thus causing sustained inflammation. In addition, by enhancing STAT3
activation, IL-6 cooperates with G-CSF to induce neutrophil production (Yan et al.,
2013). Therefore, mouse cornea developed more severe keratitis with more PMNs
infiltration when silencing of SOCS3.
In summary, our study indicates a detrimental role of IL-24 in corneal innate
immunity against PA infection: while down-regulation of IL-24 protected mouse corneas
from PA infection, exogenous IL-24 worsened PA keratitis. SOCS3, as a downstream
effector of IL-24, plays important roles in restricting the inflammation and infection, as
demonstrated by increased inflammation and more bacterial burden when silencing of
SOCS3. However, early induction of the negative regulator SOCS3 by IL-24 may
account for the detrimental effects of IL-24 in PA keratitis.
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CHAPTER 3: EXPLORE THE REGULATORY RELATIONSHIP OF IL-24 AND SOCS3
IN VITRO IN PRIMARY HUMAN CORNEAL EPITHELIAL CELLS (HCECS).
Summary
We have shown the expression patterns and functions of IL-24 and SOCS3 in a
mouse model of PA keratitis. Our next question is whether these results can be
translated into human, since our ultimate goal is to treat human diseases. We propose
that PA challenge induces IL-24 expression in HCECs, and IL-24 regulates SOCS3
expression. It is reported that human keratinocytes express IL-20R cytokines when
challenged with MRSA or treated with IL-1β (Myles et al., 2013). Therefore, IL-24
expression may be triggered by PA, and further induced by IL-1β as the infection and
inflammation continue. The induction of negative regulator by IL-24 would be consistent
with its anti-inflammatory property as a member in the IL-10 family.
The importance of corneal epithelial cells has been demonstrated in innate
immune defense against pathogen invasion. Primary human corneal epithelial cells
were used to evaluate whether IL-20R cytokines can be induced when challenged with
heat-killed PA. Consistent with the mouse model, PA challenge induced early
expression of IL-24 and late expression of IL-19 in primary HCECs: IL-24 expression
gradually increased during the course of PA challenge, while the up-regulation of IL-19
was only detected at 4 h post challenge. In contrast to the mouse model, heat-killed PA
challenge also induced IL-20 expression in primary HCECs, with peak expression at 2 h
and a subsidence at 4 h post challenge. Therefore, heat-killed PA can induce the
expression of IL-20R cytokines in primary HCECs. When primary HCECs were treated
with human recombinant protein, recombinant IL-24 can readily induce SOCS3
expression, whereas the same amount of recombinant IL-20 failed to do so. These
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results indicate that the regulatory relationship of IL-24 and SOCS3 identified in the
mouse model is relevant to human. The increased IL-20 expression in primary HCECs
may mediate other effects in response to PA challenge. IL-1β, as a master regulator of
immune response, promotes the expression of IL-20R cytokines. However, both IL-24
and IL-20 cannot induce the expression of inflammatory cytokine IL-1β or IL-6 in primary
HCECs, further confirming their immune regulatory role as members in the IL-10 super
family.
Introduction
IL-20R cytokines share identical receptors, especially for IL-24 and IL-20,
indicating their functions may be interchangeable between species. It is reported that
during mouse skin infection with MRSA, both IL-19 and IL-24 are induced during the
initial hours of infection, with more abundance of IL-19 than IL-24 in the later stage of
infection; no elevated of IL-20 was detected. However, primary human keratinocytes
produced more IL-20 than either IL-19 or IL-24 in the initial hour when challenge with
MRSA. Thus, the author concluded that human IL-20 might mirror the effects of IL-19
seen in mice during cutaneous infection (Myles et al., 2013). The expression patterns of
IL-20R cytokines in primary HCECs in response to PA are still unknown.
IL-1β, as an early responsive gene and a master regulator of innate immunity,
may induce other cytokine expression in PA keratitis. It is reported that IL-1β can induce
the expression of all three IL-20R cytokines in keratinocytes, with IL-19 being the most
prominent one (1000 folds comparing to 10 folds of IL-20 or IL-24) (Kunz et al., 2006).
In addition, IL-1β can activate the transcription factors AP-1 and C/EBP-β to promote IL24 expression in human isolated colonic subepithelial myofibroblasts (Andoh et al.,
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2009). In contrast, Myles reported IL-20R cytokines can promote cutaneous infection
with MRSA through the suppression of IL-1β (Myles et al., 2013). The regulatory
relationship of IL-1β and IL-24 in corneal epithelial cells, however, remains unknown.
In this study, by using in vitro cell culture system, we demonstrated that heatkilled PA challenge induced IL-20R cytokine expression in primary HCECs. While IL-1β
promoted IL-20R cytokine expression, IL-24 only induced robust SOCS3 expression,
but not inflammatory cytokine expression in HCECs.
Results
Heat-killed PA induces IL-20R cytokine expression in primary HCECs
To determine whether HCECs express IL-20R cytokines in response to bacterial
challenge, primary HCECs were treated with heat-killed PA (MOI=50). Cells were
collected at various time points for PCR analysis to evaluate related cytokine expression
(Fig. 28). Heat-killed PA stimulated progressive upregulation of IL-24 in cultured
HCECs. The expression of IL-20 increased gradually at the first 2 hours, but subsided to
a level equivalent to control at hour 4. SOCS3 expression significantly elevated during
the first 2 hours of stimulation and subsided to control level at hour 4 as well. Consistent
with the results obtained from mouse CECs, IL-19 was not induced until a later time
point, at hour 4. As to the inflammatory cytokines, heat-killed PA induced marked
elevation of IL-6 and IL-1β at hour 1 and subsided, but remained significantly higher
than control, at hour 4. IL-1RN was increased sharply at hour 1 but quickly reduced to
control level at hour 2.
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Figure 28 In vitro, PA challenge induces early expression of IL-24, IL-20 and
SOCS3 in primary human corneal epithelial cells (HCECs). Primary HCECs (P3
or P4) were starved overnight, and then challenged with heat-killed PA (MOI=50:1)
for 1 h, 2h, or 4 h. Cells were subjected to RNA extraction for qPCR analysis of IL-19,
IL-20, IL-24, SOCS3, IL-6, IL-1β, and IL-1RN. Results are presented relative to those
of unchallenged control cells, set as 1. *P < 0.05, **P < 0.01, and ***P < 0.001
(ANOVA). Data are representative of two independent experiments with at least three
samples per group (mean+s.e.m.).

IL-24 specifically induces SOCS3 expression in HCECs
Our in vivo data demonstrate that both IL-1β and IL-24 are the downstream
factors of toll-like receptors. These two cytokines may regulate the expression of each
other, as well as other genes involved in the innate defense of the corneas. To this end,
we first treated primary HCECs with recombinant human IL-1β and measured cytokine
expression (Fig. 29A). The mRNA expression of IL-24 was induced rapidly at hour 1
and remained high at hour 2. IL-1β also induced the expression of SOCS3, IL-1β (selfamplification), and IL-6 (Fig. 29A). The level of SOCS3 mRNA was elevated to 2.2 fold
at hour 1 and further elevated to 6.1 fold at 2 hours post IL-1β stimulation. IL-1β induced
the mRNA expression of IL-1β with similar levels at hours 1 and 2. IL-6 expression was
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observed to be greater at hour 1 than at hour 2. While significantly elevated IL-19
expression was only seen at 2 h, the expression of IL-20 was induced at hour 1 and
further elevated at hour 2. Conversely, recombinant IL-24 stimulated robust
upregulation of SOCS3 at hour 1, followed by a drastic decline, yet still significantly
higher than the control, at hour 2. IL-24 treatment exhibited no effect on the expression
of IL-1β, IL-24, or IL-6, suggesting that IL-24 functions primarily to induce the
expression of the negative regulator, SOCS3, in HCECs (Fig. 29B).

Figure 29 Effects of recombinant human IL-1β or IL-24 on primary human
corneal epithelial cells (HCECs). (A) HCECs were treated with recombinant
human IL-1β (50ng/ml). Cells were collected at 1h and 2h for qPCR analysis of
SOCS3, IL-24, IL-1β, IL-6, IL-19, and IL-20. (B) HCECs were treated with
recombinant human IL-24 (100ng/ml). Cells were collected at 1h and 2h for qPCR
analysis of SOCS3, IL-1β, IL-24, and IL-6. Results are presented relative to those
of untreated control cells, set as 1 (mean+s.e.m.). **P < 0.01, and ***P < 0.001
(ANOVA). Data are representative of three independent experiments.
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Since IL-20 was also elevated at the early time point of PA stimulation in primary
HCECs in vitro, in contrast to no elevation in mouse CECs in vivo, we treated HCECs
with recombinant human IL-20 to evaluate its effects on cytokine expression.
Surprisingly, when we treated the cells with 100ng/ml of recombinant IL-20, the same
dose as recombinant IL-24, no expression of SOCS3 was detected by qPCR (Fig. 30A).
Then we increased the dosage of recombinant IL-20 to 500ng/ml and found that high
dose of recombinant IL-20 activated STAT3 (Fig. 30B and C). The high dose of IL-20,
which is unlikely to be the amount produced in vivo, induced slight, although significant,
elevation of SOCS3 expression (2.2-fold increase) at hour 1 and returned back to
control level at hour 2 (Fig. 30D). High dose of recombinant IL-20 failed to induce
inflammatory cytokine IL-6 and IL-1β expression in HCECs (Fig. 30D).
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Figure 30 Even high dosage of recombinant IL-20 only slightly induces
SOCS3 expression. (A) HCECs were treated with low dosage of recombinant
human IL-20 (100ng/ml). Cells were collected at 1h, 2h, and 4h for qPCR
analysis of SOCS3. (B) HCECs were treated with high dose of recombinant IL20 (500ng/ml). Whole cell lysate was collected at 15 min and 30 min to detect
the activation of STAT3. β-actin was used as loading control. (C) Quantification
of protein levels based on the densitometry of the Western blots in B. (D)
HCECs were treated with high dosage of recombinant human IL-20 (500ng/ml).
Cells were collected for qPCR analysis of SOCS3, IL-1β, and IL-6. PCR results
are presented relative to those of untreated control cells, set as 1
(mean+s.e.m.). Data are representative of two independent experiments.

Discussion
Among the members of IL-20R cytokines, their temporal and spatial specific
expression pattern and distinct receptor-ligand interaction may determine their unique
biological functions; despite they share the same receptor complexes (Logsdon et al.,
2012; Parrish-Novak et al., 2002). IL-19 is not an early responsive gene in response to
PA infection: elevated expression was first detected at 18hpi in mouse cornea and at 4h
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after challenge in primary HCECs. IL-20, not induced in mouse cornea, was detected in
primary HCECs after PA challenge. IL-24 readily induces SOCS3 expression in HCECs.
However, even large dosage of IL-20 can only slightly induce SOCS3 expression (2.2fold increase by 500ng/ml IL-20 verses 11.2-fold increase by 100ng/ml IL-24). Although
the activity of recombinant proteins awaits to be determined, one explanation is that IL20 may induce other effects in HCECs. Another explanation is that IL-20 has lower
affinity to receptor complex than IL-24. It is reported that only large concentration of
anti-IL-20R2 can block IL-24 activity in comparison with IL-20 activity, indicating the
lower affinity of IL-20 to the receptors (Sa et al., 2007). In addition, no growth inhibitory
effect was detected with IL-20 in ovarian carcinoma cell line comparing to IL-19 or IL-24
even in the same cytokine concentration. The author explained that one possibility is the
lower affinity of IL-20 to the receptor complex. When tested at the same concentration,
the saturation kinetics are reached for IL-19 and IL-24, but not IL-20 (Parrish-Novak et
al., 2002). Since we did not detect elevated expression of IL-1β or IL-6 when the cells
were treated with high dosage of recombinant human IL-20, the contamination of LPS in
the recombinant protein can be excluded. Therefore, although IL-20R cytokines share
the same receptor complex and signaling pathway, they may possess their individual
properties and thus foretell their different functions.
IL-1β can induce IL-20R cytokine expression. It is reported that IL-20R cytokines,
but not IL-6, suppressed IL-1β production in mouse keratinocytes when challenged with
MRSA (Myles et al., 2013). Our data revealed that in HCECs, IL-24 exhibited no effects
on IL-1β expression but mediated the expression of SOCS3 in response to infection,
suggesting the action of IL-24 may be cell, tissue, and/or pathogen specific. SOCS3
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plays important roles in mounting immune response against pathogens, while
suppressing excessive inflammation to avoid damage to the host. However, some
pathogens can modify host SOCS3 expression to evade the immune response. Our
data suggest that PA may have evolved to take advantage of the immunosuppressive
property of the IL-24/STAT3/SOCS3 cascade to favor its survival and proliferation in the
host; this, however, awaits further investigation. In fact, studies have shown that
evolutionarily pathogens have exploited the anti-inflammatory function of IL-10 to
facilitate their survival and cause chronic infection (Ouyang et al., 2011).
In sum, our study demonstrated that heat-killed PA challenge induced early IL-24
and IL-20 expression, and late IL-19 expression in primary HCECs. IL-24 induced
robust SOCS3 expression, but not the expression of the inflammatory cytokines often
associated with microbial keratitis. The readiness of IL-24 inducing the negative
regulator expression highlights its anti-inflammatory property.
OVERALL SUMMARY
The present study demonstrated that among the three IL-20R cytokines, only IL24 was markedly induced at 3 hpi, followed by a great decline and a gradual increase;
while IL-1β expression was steadily increased during the course of infection.
Interestingly, SOCS3 shared a similar expression pattern with IL-24; while the
expression of another STAT3 activator, IL-6, was not increased until 9 hpi. Functional
studies revealed that while exogenous IL-24 increased the severity of PA keratitis, the
downregulation of the IL-24 signaling pathway resulted in reduced clinical scores, less
opacity, lower bacterial burden, and reduced infiltration of neutrophils. At the early stage
of infection (6 hpi) when most invading pathogens remained at the epithelial layer,
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downregulation of IL-24 markedly increased the infection-induced expression of AMPs
S100A8 and A9; while the expression of IL-1β, its natural inhibitor, IL-1RN, MMP13, and
SOCS3 was decreased. At 1 dpi, the expression of the inflammatory cytokines, (IL-1β,
IL-6, IL-17A, pathogenic factor MMP13), S100A8/A9, CRAMP, and SOCS3 was all
markedly elevated in infected corneas. Elevations in expression were repressed to
different extents by IL-24 downregulation. We also demonstrated that IL-24 was a major
inducer of the activation of STAT3, and the expression of its negative regulator, SOCS3,
at the early stages of infection. SOCS3 was shown to be required for controlling the
progress of PA keratitis. In vitro study using cultured HCECs revealed that while IL-1β
induced the expression of a battery of cytokines, including itself and SOCS3, IL-24
induced only the expression of SOCS3. Taken together, our data suggest that IL-24 is
an early response gene involved in corneal innate immune defense and inflammation.
The induction of SOCS3 at early stages of infection by IL-20R cytokines may interfere
with the inflammatory response necessary for effective innate immune defense against
microbial infection. This raises the concern for the use of IL-24 as an anticancer agent,
because it may render patients more susceptible to opportunistic infection at a time
when their immune systems are already comprised. In the cornea, downregulation of IL24 may be used as an effective mean to boost innate immunity, and hence to reduce
the rate of infection by opportunistic ocular pathogens such as PA.
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Figure 31 Schematic graph summarizing part of the signaling pathways
involved in IL-24/STAT3/SOCS3 signaling events. In summary, in the case of
PA infection, the surface components of PA, such as flagellin and LPS, are
sensed by TLRs in corneal epithelial cells. Signals are transduced by MyD88
and NF-κB pathway to induce IL-24 and inflammatory cytokine expression. IL24, by binding to its heterodimer receptors in corneal epithelial cells, activates
JAK/STAT3 signaling pathway to induce early expression of the negative
regulator SOCS3. SOCS3 negatively regulates STAT protein activation,
including STAT1 and STAT3 to suppress the necessary inflammatory response.
Interferon signaling pathway plays an important role in both bacterial and fungal
infection. By activating STAT1/STAT3, interferon can regulate CXCL10
expression, which processes direct antimicrobial activity. When silencing of IL24, interferon pathway is activated with less restriction of negative regulator
SOCS3; therefore, more CXCL10 is produced to clear the pathogens in corneal
epithelial cells, resulting in less keratitis seen in IL-24 silencing group. SOCS3 is
an important negative regulator, but what matters is the timing of its expression.
We believe that trying to shut down the necessary immune response at an early
time point is detrimental to the host to control infection. As infection and
inflammation continue, inflammatory cytokine IL-1β may further induce IL-24
expression, which cause a cascade of inflammation and is detrimental to the
host.
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MATERIALS AND METHODS
Animals
Wild-type C57BL/6 mice (8 weeks, female) were purchased from The Jackson
Laboratory (Bar Harbor, ME, USA). MyD88 knockout mice were kindly provided by Dr.
Ashok Kumar. The knockout mice were bred in our Institutional Animal Care Facility and
genotyped before use to ensure their gene deficiency. All animal procedures were
performed in compliance with the ARVO Statement on the use of animals in Ophthalmic
and Vision Research and were approved by the Institutional Animal Care and Use
Committee of Wayne State University.
Flagellin preparation
Flagellin was prepared from PA strain PAO1 as previously reported (Gao et al.,
2010; Zhang et al., 2003). Briefly, flagellin was isolated from PAO1 by ammonium
sulfate precipitation, followed by DEAE-Sephadex A-50 chromatography. LPS was
removed by using Detoxi-Gel Affinity Pak columns (Pierce, Rockford, IL). A quantitative
Limulus amebocyte lysate kit was used to detect the amount of LPS in the flagellin
samples. After the two chromatography steps, LPS level was 0.0027 endotoxin unit/µg
protein. By this method, up to 1,000 ng/ml purified flagellin was unable to stimulate
HeLa cells with functional TLR4, CD14, and MD2 (Re and Strominger, 2002), which are
otherwise activated by 1 ng/ml purified PA LPS (Sigma, St. Louis, MO, USA).
Bacterial strain
P. aeruginosa strain ATCC 19660 was used in this study. ATCC 19660 is the
most virulent strain. It can cause keratitis in B6 mouse at 1.0 x 104 CFUs/cornea. PA
was maintained on tryptic soy (Sigma-aldrich, St. Louis, MO, USA) agar plates at 4 °C.
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For use in experiments, a colony of PA from the tryptic soy agar plate was cultured in
liquid tryptic soy broth medium at 37 °C overnight under shaking. PA were harvested by
centrifugation (5000 rpm for 5 min) and resuspended in sterile PBS. According to a
predertermined OD600 conversion factor: OD600 =0.5 corresponding to 1×108 CFUs/ml
bacteria, dilute the bacteria with PBS to yield 2×106 CFUs/ml bacteria for the in vivo
studies. (OD600 is measured at Spectrophotometer, Eppendorf Biophotometer D30,
Germany)
Mouse model of P. aeruginosa Keratitis
Mice were anesthetized with an intraperitoneal injection of Ketamine (90 mg/kg)
and Xylazine (10 mg/kg) before surgical procedures. Mouse corneas were scratched
gently with a sterile 26-gauge needle to create three 1-mm incisions to break the
epithelial barrier. Purified flagellin (500ng in 5µl PBS) was applied topically to the injured
cornea as an eye drop. PBS was used as control. Twenty-four hours later, the corneas
were scratched again and inoculated with 1.0×104 CFUs of ATCC 19660 in 5µl PBS.
The application of siRNA, recombinant protein, or neutralizing antibody
All the siRNAs used in this study were SMARTpool (a mixture of 4 siRNAs) ONTARGETplus siRNAs designed by GE Dharmacon Company (Lafayette, CO, USA).
Mice were subconjunctivally injected twice with siRNA targeting to a specific gene
(10µM/ul, 5µl) over 2 days. Six hours after the second siRNA injection, mouse corneas
were inoculated with PA to observe the silencing effects of the specific gene on
infection. To apply recombinant protein or neutralizing antibody, mice were
subconjuntivally injected with recombinant mouse IL-24 (200ng/5ul, 7807-ML-010; R&D
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systems, Minneapolis, MN, USA), or anti-IL-20R2 (200ng/5ul, 14-1206; eBioscience,
San Diego, CA, USA) 4 hours before the inoculation with PA on the corneas.
Clinical examination, quantification of PA colony forming units (CFUs) and
myeloperoxidase (MPO) units
The mice were monitored and the corneas were photographed daily up to 3dpi
for the assessment of infection severity. Clinical scores were assigned to the infected
corneas in a blind fashion according to the scale previously reported (Wu et al., 2003)
(Table 4). A total possible score ranging from 0 to 12 will be designated to an infected
cornea. A total score ≤ 5 is categorized as mild, 6-9 as moderate, and ≥9 as severe
infection.
Table 4 Visual clinical scoring system for murine keratitis. (Wu et al., 2003)

Whole corneas were excised from the eyes and put in 200µl sterile PBS. Tissue
was homogenized with TissueLyser II (Qiagen, Valencia, CA, USA) at 30Hz for 3 min.
The homogenates were divided into two parts. The first part (50µl) was subjected to
serial log dilutions and then plated onto TS agar plate in duplicate for the assessment of
bacterial viability. Following overnight incubation at 37 °C, the number of CFUs was
determined by direct counting. The remaining homogenates was further lysed with the
lysate buffer, 1% SDS and 10% Triton X-100 in PBS (5µl for 50µl sample).
For MPO measurement, 60µl of homogenates were put into 240µl of
hexadecyltrimethylammonium bromide (HTAB) buffer (0.5% HTAB in 50mM potassium
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phosphate buffer, pH=6.0). The samples underwent four freeze-thaw cycles, followed by
sonication on ice (3 sec × 3 times) (Sonic Dismembrator model 100, Fisher Scientific,
Waltham, MA, USA). Subsequently, the samples were centrifuged at 14,000 rpm for 30
min to obtain supernatant. In a 96-well plate, 20µl of supernatant was mixed with 180µl
phosphate buffer (50mM, pH=6.0) containing O,O-dianisidine hydrochloride (16.7
mg/100mL) and 0.0005% hydrogen peroxide. MPO units were measured immediately in
absorbance at 460 nm continuously for 5 min with a microplate reader (Synergy2;
BioTek, Winooski, VT, USA). The results were expressed in MPO units per cornea. 1
MPO unit corresponds to 2.0×105 polymorphonuclear leucocytes (PMNs) (Williams et
al., 1982).
Semi-quantitative and quantitative PCR
Gene specific primers were designed by using online Primer3 software system
and purchased from Integrated DNA Technologies (IDT), Inc. (Coralville, Iowa, USA).
The primers used in this study are listed in Table 5. Total RNA was extracted with
RNeasy Mini Kit (Qiagen, Valencia, CA, USA) following the manufacturer’s instructions.
RNA was reversed-transcribed to cDNA with a first-strand synthesis system (Derkin
Elmer Letus, DNA Thermal Cycler 480, Norwalk, CT, USA). For semi-quantitative PCR,
cDNA was amplified with TaqMan technology (Promega, Madison, WI, USA). PCR
products were subjected to electrophoresis on 2% agarose gels containing ethidium
bromide. GAPDH was used as loading control. Stained gels were captured with a digital
camera under UV transillumination.
For quantitative PCR, cDNA was amplified using StepOnePlus Real-Time PCR
system (Applied Biosystems, University Park, IL, USA) with the SYBR® Green PCR
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Master Mix (Applied Biosystems). Melting curve and dissociation curve analyses were
used to confirm the utility of each pair primers and ensure only the desire product was
amplified, respectively. Data were analyzed by using ΔΔCT method with β-actin or
GAPDH as the internal control. Relative mRNA levels in each group were obtained from
the means of three or four biological independent experiments.
Table 5 PCR primer sequences used in this study.
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ELISA
For cytokine measurement, homogenates from mouse cornea samples were
sonicated and centrifuged to obtain supernatant. Protein concentration was determined
by BCA assay with Thermo Scientific Pierce BCA Protein Assay Kit (Micro BCA, Pierce,
Rockford, IL, USA). The amount of cytokines was determined by ELISA assay
according to manufacturer’s instructions (mouse IL-1β: DY401; mouse IL-1RA: MRA00;
mouse IL-6: DY406; mouse S100A8/9: DY8596-05; R&D Systems, Minneapolis, MN,
USA).
Western Blot
Mouse corneal samples were lysed with RIPA buffer. The lysates were
centrifuged to obtain supernatant. Protein concentration was determined by BCA assay.
The protein samples were separated by SDS-PAGE and electrically transferred onto
nitrocellulose membranes (Bio-Rad; Hercules, CA, USA). The membranes were stained
with 2% Ponceau S. to visualize all proteins. According to prestained protein molecular
size marker and the molecular weights of interested proteins, the membranes were cut
into strips. Then the strips were blocked with 3% BSA for at least 1h at room
temperature, followed by incubation with primary antibodies overnight at 4°C. After
several washes with Tris-buffered saline/0.05%Tween 20 (TBST), the strips were
incubated with HRP-conjugated secondary antibodies. Signals were visualized using
SuperSignal® West Pico Chemiluminescent Substrate (Thermo Scientific, Pittsburgh,
PA, USA). β-actin was used as the loading control. Antibodies: anti-IL-24 (ab182567;
Abcam, Cambridge, MA, USA); anti-SOCS3 (#2923; Cell signaling, Danvers, MA, USA);
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anti-STAT3 (#4904; Cell signaling); anti-phospho-STAT3 (Tyr705) (#9145; Cell
signaling); and anti-β-actin (A1978; Sigma).
STAT3 has two isoforms: STAT3α (86 kDa) and STAT3β (79 kDa). Their relative
expression levels depend on ligands, cell types, and maturation state of cells (Biethahn
et al., 1999). Therefore, Western blot shows two bands for both p-STAT3 and STAT3.
Quantification of protein levels was based on the densitometry of blots by using the
software Carestream MI SE (Informer Technologies the Western blots, Inc.). Rectangles
were drawn to include the bands manually. When the target protein has two bands, both
two bands would be included in the rectangle. Analyze the bands to get net intensity.
The target protein would first compare with the control in the same group and then
normalize with β-actin to get a relative density. The results were plotted as mean+s.e.m.
to get a bar graph.
Primary human corneal epithelial cell culture
Primary human corneal epithelial cells (HCECs) were obtained from diseased
human corneal samples. Corneal epithelial cells were dislodged from underlying
basement membrane by dispase and then digested by trypsin. Cells were pelleted, resuspended and grown in defined keratinocyte serum-free medium (DK-SFM) (Gibco,
Waltham, MA USA) with supplements and antibiotics (penicillin and streptomycin).
P3 or P4 of the primary HCECs were used for the experiments. Before treatment,
cells were starved overnight in growth factor-free and antibiotic-free keratinocyte basic
medium (KBM-2, Lonza, Basel, Switzerland). Subsequently, cells were challenged with
heat-killed ATCC with MOI=100:1 (MOI was determined according to previous report (Ni
et al., 2008)) or treated with recombinant human IL-1β (50ng/ml, 201-LB; R&D systems,
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Minneapolis, MN, USA) (Dosage was determined according to previous report (Cella et
al., 2010)), recombinant human IL-24 (100ng/ml, 1965-IL-025; R&D systems), or
recombinant human IL-20 (100ng/ml or 500ng/ml, 1102-IL-025; R&D systems) (The
dosage of both IL-24 and IL-20 was determined according to previous report (Kreis et
al., 2007)). At the end of the incubation period, cells were harvested to detect gene
expression. Time points were determined according to previous report (Zhang et al.,
2009).
Primary mouse bone marrow-derived macrophage (BMDM) culture
Wild-type C57BL/6 mice (8 weeks) were euthanized by rapid cervical dislocation.
Using aseptic technique, femur was dissected out and sterilized with gentamycin in PBS
(20ug/ml). Bone marrow was flushed with RPMI-1640 (Gibco, Carlsbad, CA)
supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, 100 μg/mL
streptomycin, and 50 mM 2-mercaptoethanol. Red blood cells (RBC) were lysed with
RBC Lysis Buffer. Cells were plated on non-tissue culture treated petri dishes and
differentiated into macrophages in the presence of mouse recombinant macrophage
colony stimulating factors (M-CSF, 20 ng/ml; PeproTech, Rocky Hill, NJ). After 7 days of
differentiation period, BMDM were used for experiments.
The efficiency of the differentiation was assessed using Flow Cytometry analysis
of Mac-1 and F4/80 surface antigen expression. Cells were washed with PBS and
harvested by trypsinization, followed by incubation with Fc Block (anti-mouse CD16/32,
1:100 dilution, BD, San Jose, CA) for 20 min at room temperature. Then cells were
washed incubated with FITC-conjugated anti-F4/80 (1:100 dilution, BD) and PEconjugated anti-Mac-1 (1:100 dilution, BD) antibodies for 30 min in the dark. Cells were
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washed and resuspended with 2% FBS in PBS. Flow cytometry was used to analyze
the cells. Macrophages are double-positive for F4/80 and Mac-1.
For experiments, BMDMs were plated into 12-well plates. The next day, cells
were starved with RPMI 1640 medium supplemented with 1% FBS for 1h. Then BMDMs
were treated with either heat-killed PA (MOI=50) for 2h. Cells were collected for western
blot analysis.
Statistical analysis
A nonparametric Mann-Whitney U test was used to compare the clinical scores.
Student t-test or one-way ANOVA was used to compare quantitative means. P-value <
0.05 was considered to be significant.
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ABSTRACT
EXPRESSION AND FUNCTIONS OF IL-24 AND SOCS3 IN PSEUDOMONAS
AERUGINOSA KERATITIS IN A C57BL/6 MOUSE MODEL
by
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Advisor: Dr. Fu-shin Yu
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Degree: Doctor of Philosophy
The aim of this study was to elucidate the expression and functions of interleukin
(IL)-24 and suppressor of cytokine signaling 3 (SOCS3), and their regulatory
relationship in C57BL/6 mouse corneas in response to Pseudomonas aeruginosa (PA)
infection. Among IL-20R cytokines, only IL-24 was induced at both mRNA and protein
levels by the infection, and this upregulation was dampened by flagellin pretreatment.
Time course studies revealed that IL-24 expression was markedly elevated, followed by
a subsidence and second elevation, a pattern shared with SOCS3 but not IL-1β or IL-6.
Silencing of IL-24 enhanced S100A8/A9 expression, and suppressed SOCS3, IL-1β, IL1RN, and MMP13 expression during an early stage of infection. Downregulation of IL-24
signaling pathway significantly reduced the severity of keratitis, bacterial burden, and
neutrophil infiltration; while recombinant IL-24 exacerbated PA keratitis. Furthermore,
SOCS3 knockdown impaired the control of PA keratitis. In vitro, while IL-1β induced the
expression of SOCS3, IL-24, IL-1β, and IL-6, IL-24 only elicited robust expression of
SOCS3 in primarily cultured human corneal epithelial cells. In conclusion, IL-24
promotes PA keratitis by inducing SOCS3 expression, resulting in the suppression of
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the necessary inflammatory response at an early stage of infection, and in the increased
severity of PA keratitis.
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